(451559, 'HP:0011953', 'Pulmonary lymphoma', 'MP:0002309', 'abnormal vital capacity', 0.425531914893617, 9.915985363358194, 2.054158766923066, 'UPHENO:0019970', 'abnormal lung morphology'),
(451560, 'HP:0011953', 'Pulmonary lymphoma', 'MP:0010938', 'decreased total lung capacity', 0.40816326530612246, 9.915985363358194, 2.0118004286300364, 'UPHENO:0019970', 'abnormal lung morphology'),
(451561, 'HP:0011953', 'Pulmonary lymphoma', 'MP:0002313', 'abnormal tidal volume', 0.425531914893617, 9.915985363358194, 2.054158766923066, 'UPHENO:0019970', 'abnormal lung morphology'),
(451562, 'HP:0011953', 'Pulmonary lymphoma', 'MP:0002312', 'abnormal inspiratory reserve volume', 0.425531914893617, 9.915985363358194, 2.054158766923066, 'UPHENO:0019970', 'abnormal lung morphology'),
(451563, 'HP:0011953', 'Pulmonary lymphoma', 'MP:0002304', 'abnormal total lung capacity', 0.4166666666666667, 9.915985363358194, 2.032648658294373, 'UPHENO:0019970', 'abnormal lung morphology'),
(451564, 'HP:0011953', 'Pulmonary lymphoma', 'MP:0005586', 'decreased tidal volume', 0.4166666666666667, 9.915985363358194, 2.032648658294373, 'UPHENO:0019970', 'abnormal lung morphology'),
(451565, 'HP:0011953', 'Pulmonary lymphoma', 'MP:0002337', 'abnormal whole-body plethysmography', 0.425531914893617, 9.915985363358194, 2.054158766923066, 'UPHENO:0019970', 'abnormal lung morphology'),
(451566, 'HP:0011953', 'Pulmonary lymphoma', 'MP:0002308', 'abnormal residual volume', 0.425531914893617, 9.915985363358194, 2.054158766923066, 'UPHENO:0019970', 'abnormal lung morphology'),
(451567, 'HP:0011953', 'Pulmonary lymphoma', 'MP:0002311', 'abnormal inspiratory capacity', 0.425531914893617, 9.915985363358194, 2.054158766923066, 'UPHENO:0019970', 'abnormal lung morphology'),
(451568, 'HP:0011953', 'Pulmonary lymphoma', 'MP:0010937', 'increased total lung capacity', 0.40816326530612246, 9.915985363358194, 2.0118004286300364, 'UPHENO:0019970', 'abnormal lung morphology'),
(451569, 'HP:0011953', 'Pulmonary lymphoma', 'MP:0001942', 'abnormal lung volume', 0.43478260869565216, 9.915985363358194, 2.0763665341333115, 'UPHENO:0019970', 'abnormal lung morphology'),
(451570, 'HP:0011953', 'Pulmonary lymphoma', 'MP:0002306', 'abnormal functional residual capacity', 0.425531914893617, 9.915985363358194, 2.054158766923066, 'UPHENO:0019970', 'abnormal lung morphology'),
(451571, 'HP:0012030', 'Increased urinary cortisol level', 'MP:0011546', 'increased urine progesterone level', 0.4430379746835443, 14.491670050491338, 2.533842960594018, 'UPHENO:0068452', 'increased level of ketone in urine'),
(451572, 'HP:0012030', 'Increased urinary cortisol level', 'MP:0011540', 'increased urine aldosterone level', 0.43209876543209874, 14.491670050491338, 2.502365428522906, 'UPHENO:0068452', 'increased level of ketone in urine'),
(451573, 'HP:0012030', 'Increased urinary cortisol level', 'MP:0011553', 'increased urine deoxycorticosterone level', 0.5, 14.491670050491338, 2.6918088760619074, 'UPHENO:0068452', 'increased level of ketone in urine'),
(451574, 'HP:0012030', 'Increased urinary cortisol level', 'MP:0011549', 'increased urine corticosterone level', 0.46835443037974683, 14.491670050491338, 2.6052327864797626, 'UPHENO:0068452', 'increased level of ketone in urine'),
(451575, 'HP:0031678', 'Atherosclerotic lesion', 'MP:0012562', 'blood vessel degeneration', 0.42105263157894735, 6.6481113184978895, 1.6730824144922813, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(451576, 'HP:0031678', 'Atherosclerotic lesion', 'MP:0000265', 'blood vessel atresia', 0.42105263157894735, 6.6481113184978895, 1.6730824144922813, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(451577, 'HP:0006894', 'Hypoplastic olfactory lobes', 'MP:0000851', 'cerebellum hypoplasia', 0.42105263157894735, 8.202005804774931, 1.858353068802128, 'UPHENO:0081790', 'anatomical entity hypoplasia in independent continuant'),
(451578, 'HP:0006894', 'Hypoplastic olfactory lobes', 'MP:0012092', 'diencephalon hypoplasia', 0.4807692307692308, 8.202005804774931, 1.9857673633954227, 'UPHENO:0081790', 'anatomical entity hypoplasia in independent continuant'),
(451579, 'HP:0006894', 'Hypoplastic olfactory lobes', 'MP:0012264', 'hindbrain hypoplasia', 0.42105263157894735, 8.202005804774931, 1.858353068802128, 'UPHENO:0081790', 'anatomical entity hypoplasia in independent continuant'),
(451580, 'HP:0006894', 'Hypoplastic olfactory lobes', 'MP:0020570', 'decreased premotor cortex size', 0.42105263157894735, 8.700256672302757, 1.9139660308598403, 'UPHENO:0087531', 'abnormal cerebral hemisphere morphology'),
(451581, 'HP:0006894', 'Hypoplastic olfactory lobes', 'MP:0002741', 'small olfactory bulb', 0.45454545454545453, 11.359219754467691, 2.2722855688879036, 'UPHENO:0087712', 'abnormal olfactory lobe morphology'),
(451582, 'HP:0006894', 'Hypoplastic olfactory lobes', 'MP:0020069', 'decreased neocortex size', 0.42105263157894735, 8.700256672302757, 1.9139660308598403, 'UPHENO:0087531', 'abnormal cerebral hemisphere morphology'),
(451583, 'HP:0006894', 'Hypoplastic olfactory lobes', 'MP:0010059', 'olfactory bulb hypoplasia', 0.49122807017543857, 11.359219754467691, 2.3621955039085742, 'UPHENO:0087712', 'abnormal olfactory lobe morphology'),
(451584, 'HP:0006894', 'Hypoplastic olfactory lobes', 'MP:0012137', 'abnormal forebrain size', 0.4117647058823529, 9.371930806217245, 1.9644414809232182, 'UPHENO:0020888', 'abnormal forebrain morphology'),
(451585, 'HP:0006894', 'Hypoplastic olfactory lobes', 'MP:0020528', 'thalamus hypoplasia', 0.43103448275862066, 8.202005804774931, 1.8802519324931877, 'UPHENO:0081790', 'anatomical entity hypoplasia in independent continuant'),
(451586, 'HP:0006894', 'Hypoplastic olfactory lobes', 'MP:0000784', 'forebrain hypoplasia', 0.45614035087719296, 9.371930806217245, 2.0675869525475123, 'UPHENO:0020888', 'abnormal forebrain morphology'),
(451587, 'HP:0006894', 'Hypoplastic olfactory lobes', 'MP:0012476', 'decreased piriform cortex size', 0.43103448275862066, 11.359219754467691, 2.2127393455643363, 'UPHENO:0087712', 'abnormal olfactory lobe morphology'),
(451588, 'HP:0006894', 'Hypoplastic olfactory lobes', 'MP:0012468', 'decreased striatum size', 0.4107142857142857, 8.100674382308824, 1.8240237643007784, 'UPHENO:0076799', 'abnormal telencephalon morphology'),
(451589, 'HP:0006894', 'Hypoplastic olfactory lobes', 'MP:0012138', 'decreased forebrain size', 0.41818181818181815, 9.371930806217245, 1.9796896384075258, 'UPHENO:0020888', 'abnormal forebrain morphology'),
(451590, 'HP:0006894', 'Hypoplastic olfactory lobes', 'MP:0012462', 'decreased brain internal capsule size', 0.42105263157894735, 8.700256672302757, 1.9139660308598403, 'UPHENO:0087531', 'abnormal cerebral hemisphere morphology'),
(451591, 'HP:0006894', 'Hypoplastic olfactory lobes', 'MP:0020141', 'decreased brain external capsule size', 0.42857142857142855, 8.700256672302757, 1.9309793968312805, 'UPHENO:0087531', 'abnormal cerebral hemisphere morphology'),
(451592, 'HP:0006894', 'Hypoplastic olfactory lobes', 'MP:0010058', 'enlarged olfactory bulb', 0.40350877192982454, 11.359219754467691, 2.140921486931798, 'UPHENO:0087712', 'abnormal olfactory lobe morphology'),
(451593, 'HP:0006894', 'Hypoplastic olfactory lobes', 'MP:0020070', 'decreased neocortex volume', 0.41379310344827586, 8.700256672302757, 1.8973945844838724, 'UPHENO:0087531', 'abnormal cerebral hemisphere morphology'),
(451594, 'HP:0006894', 'Hypoplastic olfactory lobes', 'MP:0000866', 'cerebellum vermis hypoplasia', 0.41379310344827586, 8.202005804774931, 1.8422631289961247, 'UPHENO:0081790', 'anatomical entity hypoplasia in independent continuant'),
(451595, 'HP:0006894', 'Hypoplastic olfactory lobes', 'MP:0000785', 'telencephalon hypoplasia', 0.5098039215686274, 8.202005804774931, 2.0448507828208164, 'UPHENO:0081790', 'anatomical entity hypoplasia in independent continuant'),
(451596, 'HP:0006894', 'Hypoplastic olfactory lobes', 'MP:0006254', 'thin cerebral cortex', 0.42857142857142855, 8.700256672302757, 1.9309793968312805, 'UPHENO:0087531', 'abnormal cerebral hemisphere morphology'),
(451597, 'HP:0000914', 'Shield chest', 'MP:0031094', 'organomegaly', 0.41025641025641024, 5.9605885577567275, 1.5637677783867745, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(451598, 'HP:0000914', 'Shield chest', 'MP:0004671', 'long ribs', 0.425531914893617, 10.607147267911275, 2.1245422303340744, 'UPHENO:0087317', 'abnormal thoracic rib cage morphology'),
(451599, 'HP:0000914', 'Shield chest', 'MP:0001267', 'enlarged chest', 0.48717948717948717, 15.192109768632433, 2.7205301406631808, 'UPHENO:0001283', 'increased size of the chest'),
(451600, 'HP:0000914', 'Shield chest', 'MP:0001268', 'barrel chest', 0.475, 15.192109768632433, 2.6863082734675863, 'UPHENO:0001283', 'increased size of the chest'),
(451601, 'HP:0000914', 'Shield chest', 'MP:0010103', 'small thoracic cage', 0.4318181818181818, 11.92532322793753, 2.26926670840651, 'UPHENO:0020562', 'abnormal thoracic rib cage morphology'),
(451602, 'HP:0000914', 'Shield chest', 'MP:0010875', 'increased bone volume', 0.4186046511627907, 5.9605885577567275, 1.5795980798749651, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(451603, 'HP:0000914', 'Shield chest', 'MP:0004676', 'wide ribs', 0.43478260869565216, 10.607147267911275, 2.147510921965573, 'UPHENO:0087317', 'abnormal thoracic rib cage morphology'),
(451604, 'HP:0000914', 'Shield chest', 'MP:0004735', 'enlarged thoracic cavity', 0.4186046511627907, 12.062826751687464, 2.247121577580374, 'UPHENO:0087481', 'abnormal chest morphology'),
(451605, 'HP:0000914', 'Shield chest', 'MP:0010104', 'enlarged thoracic cage', 0.5, 11.92532322793753, 2.441856182081321, 'UPHENO:0020562', 'abnormal thoracic rib cage morphology'),
(451606, 'HP:0003085', 'Long fibula', 'MP:0004641', 'elongated metatarsal bones', 0.4666666666666667, 13.062826751687464, 2.4690050258057696, 'UPHENO:0072241', 'increased length of the long bone'),
(451607, 'HP:0003085', 'Long fibula', 'MP:0004357', 'long tibia', 0.5205479452054794, 13.062826751687464, 2.607647910314212, 'UPHENO:0072241', 'increased length of the long bone'),
(451608, 'HP:0003085', 'Long fibula', 'MP:0004348', 'long femur', 0.47368421052631576, 13.062826751687464, 2.487499703942719, 'UPHENO:0072241', 'increased length of the long bone'),
(451609, 'HP:0003085', 'Long fibula', 'MP:0030823', 'increased femur size', 0.4383561643835616, 7.694257931681313, 1.8365253591251105, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(451610, 'HP:0003085', 'Long fibula', 'MP:0000482', 'long fibula', 0.5857142857142857, 16.607147267911277, 3.1188208348311073, 'UPHENO:0072238', 'increased length of the fibula'),
(451611, 'HP:0003085', 'Long fibula', 'MP:0004695', 'increased length of long bones', 0.4032258064516129, 13.062826751687464, 2.2950531260706972, 'UPHENO:0072241', 'increased length of the long bone'),
(451612, 'HP:0003085', 'Long fibula', 'MP:0002764', 'short tibia', 0.4230769230769231, 10.757481540995707, 2.133364054825444, 'UPHENO:0086780', 'abnormal hindlimb zeugopod morphology'),
(451613, 'HP:0003085', 'Long fibula', 'MP:0008158', 'increased diameter of femur', 0.4266666666666667, 7.694257931681313, 1.8118728940474902, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(451614, 'HP:0003085', 'Long fibula', 'MP:0002765', 'short fibula', 0.4605263157894737, 13.062826751687464, 2.4527077848269667, 'UPHENO:0020827', 'abnormal fibula morphology'),
(451615, 'HP:0030925', '5-minute APGAR score of 5', 'MP:0013118', 'swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(451616, 'HP:0030925', '5-minute APGAR score of 5', 'MP:0002132', 'abnormal respiratory system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(451617, 'HP:0030925', '5-minute APGAR score of 5', 'MP:0000462', 'abnormal digestive system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(451618, 'HP:0030925', '5-minute APGAR score of 5', 'MP:0002163', 'abnormal gland morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(451619, 'HP:0030925', '5-minute APGAR score of 5', 'MP:0005499', 'abnormal olfactory system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(451620, 'HP:0030925', '5-minute APGAR score of 5', 'MP:0010678', 'abnormal skin adnexa morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(451621, 'HP:0030925', '5-minute APGAR score of 5', 'MP:0014137', 'abnormal preimplantation embryo morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(451622, 'HP:0030925', '5-minute APGAR score of 5', 'MP:0003632', 'abnormal nervous system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(451623, 'HP:0030925', '5-minute APGAR score of 5', 'MP:0003385', 'abnormal body wall morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(451624, 'HP:0030925', '5-minute APGAR score of 5', 'MP:0008923', 'thoracoschisis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(451625, 'HP:0030925', '5-minute APGAR score of 5', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(451626, 'HP:0030925', '5-minute APGAR score of 5', 'MP:0000003', 'abnormal adipose tissue morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(451627, 'HP:0030925', '5-minute APGAR score of 5', 'MP:0010233', 'hairless tail', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(451628, 'HP:0030925', '5-minute APGAR score of 5', 'MP:0020982', 'abnormal skin adnexa development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(451629, 'HP:0030925', '5-minute APGAR score of 5', 'MP:0014136', 'abnormal extraembryonic endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(451630, 'HP:0030925', '5-minute APGAR score of 5', 'MP:0003279', 'aneurysm', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(451631, 'HP:0030925', '5-minute APGAR score of 5', 'MP:0003384', 'abnormal ventral body wall morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(451632, 'HP:0030925', '5-minute APGAR score of 5', 'MP:0031310', 'abnormal cyst', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(451633, 'HP:0030925', '5-minute APGAR score of 5', 'MP:0005508', 'abnormal skeleton morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(451634, 'HP:0030925', '5-minute APGAR score of 5', 'MP:0020973', 'abnormal gland development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(451635, 'HP:0030925', '5-minute APGAR score of 5', 'MP:0002109', 'abnormal limb morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(451636, 'HP:0030925', '5-minute APGAR score of 5', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(451637, 'HP:0030925', '5-minute APGAR score of 5', 'MP:0006281', 'abnormal tail development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(451638, 'HP:0030925', '5-minute APGAR score of 5', 'MP:0002160', 'abnormal reproductive system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(451639, 'HP:0030925', '5-minute APGAR score of 5', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(451640, 'HP:0030925', '5-minute APGAR score of 5', 'MP:0000685', 'abnormal immune system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(451641, 'HP:0030925', '5-minute APGAR score of 5', 'MP:0002111', 'abnormal tail morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(451642, 'HP:0030925', '5-minute APGAR score of 5', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(451643, 'HP:0030925', '5-minute APGAR score of 5', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(451644, 'HP:0030925', '5-minute APGAR score of 5', 'MP:0000428', 'abnormal craniofacial morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(451645, 'HP:0030925', '5-minute APGAR score of 5', 'MP:0014134', 'abnormal embryo morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(451646, 'HP:0030925', '5-minute APGAR score of 5', 'MP:0013113', 'greasy tail', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(451647, 'HP:0030925', '5-minute APGAR score of 5', 'MP:0013332', 'peliosis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(451648, 'HP:0030925', '5-minute APGAR score of 5', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(451649, 'HP:0030925', '5-minute APGAR score of 5', 'MP:0002925', 'abnormal cardiovascular development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(451650, 'HP:0030925', '5-minute APGAR score of 5', 'MP:0002108', 'abnormal muscle morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(451651, 'HP:0030925', '5-minute APGAR score of 5', 'MP:0004134', 'abnormal chest morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(451652, 'HP:0030925', '5-minute APGAR score of 5', 'MP:0005500', 'abnormal gustatory system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(451653, 'HP:0002217', 'Slow-growing hair', 'MP:0008238', 'abnormal dorsoventral coat patterning', 0.40540540540540543, 9.570057949176055, 1.9697089182513596, 'UPHENO:0002768', 'abnormal strand of hair'),
(451654, 'HP:0002217', 'Slow-growing hair', 'MP:0001211', 'wrinkled skin', 0.4166666666666667, 6.904974582545727, 1.6961936041405727, 'UPHENO:0003811', 'abnormal skin of body'),
(451655, 'HP:0002217', 'Slow-growing hair', 'MP:0001197', 'oily skin', 0.40540540540540543, 6.904974582545727, 1.6731150647672055, 'UPHENO:0003811', 'abnormal skin of body'),
(451656, 'HP:0002217', 'Slow-growing hair', 'MP:0002671', 'belted', 0.40540540540540543, 9.570057949176055, 1.9697089182513596, 'UPHENO:0002768', 'abnormal strand of hair'),
(451657, 'HP:0002217', 'Slow-growing hair', 'MP:0008237', 'abnormal ventral coat pigmentation', 0.40540540540540543, 9.570057949176055, 1.9697089182513596, 'UPHENO:0002768', 'abnormal strand of hair'),
(451658, 'HP:0002217', 'Slow-growing hair', 'MP:0010202', 'focal dorsal hair loss', 0.40540540540540543, 9.570057949176055, 1.9697089182513596, 'UPHENO:0002768', 'abnormal strand of hair'),
(451659, 'HP:0002217', 'Slow-growing hair', 'MP:0000371', 'diluted coat color', 0.40540540540540543, 9.570057949176055, 1.9697089182513596, 'UPHENO:0002768', 'abnormal strand of hair'),
(451660, 'HP:0002217', 'Slow-growing hair', 'MP:0009002', 'premature hair regrowth', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(451661, 'HP:0002217', 'Slow-growing hair', 'MP:0020440', 'abnormal front foot hair pigmentation', 0.40540540540540543, 9.570057949176055, 1.9697089182513596, 'UPHENO:0002768', 'abnormal strand of hair'),
(451662, 'HP:0002217', 'Slow-growing hair', 'MP:0013116', 'focal hair loss in head/neck region', 0.40540540540540543, 9.570057949176055, 1.9697089182513596, 'UPHENO:0002768', 'abnormal strand of hair'),
(451663, 'HP:0002217', 'Slow-growing hair', 'MP:0003196', 'calcified skin', 0.42857142857142855, 6.904974582545727, 1.7202542896592428, 'UPHENO:0003811', 'abnormal skin of body'),
(451664, 'HP:0002217', 'Slow-growing hair', 'MP:0000397', 'abnormal guard hair morphology', 0.4411764705882353, 9.570057949176055, 2.0547711282141323, 'UPHENO:0002768', 'abnormal strand of hair'),
(451665, 'HP:0002217', 'Slow-growing hair', 'MP:0009934', 'abnormal hind foot hair pigmentation', 0.40540540540540543, 9.570057949176055, 1.9697089182513596, 'UPHENO:0002768', 'abnormal strand of hair'),
(451666, 'HP:0002217', 'Slow-growing hair', 'MP:0010203', 'focal ventral hair loss', 0.40540540540540543, 9.570057949176055, 1.9697089182513596, 'UPHENO:0002768', 'abnormal strand of hair'),
(451667, 'HP:0002217', 'Slow-growing hair', 'MP:0012076', 'abnormal agouti pigmentation', 0.40540540540540543, 9.570057949176055, 1.9697089182513596, 'UPHENO:0002768', 'abnormal strand of hair'),
(451668, 'HP:0002217', 'Slow-growing hair', 'MP:0002075', 'abnormal coat/hair pigmentation', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(451669, 'HP:0002217', 'Slow-growing hair', 'MP:0001510', 'abnormal coat appearance', 0.4411764705882353, 9.570057949176055, 2.0547711282141323, 'UPHENO:0002768', 'abnormal strand of hair'),
(451670, 'HP:0002217', 'Slow-growing hair', 'MP:0013117', 'focal hair loss in thorax region', 0.40540540540540543, 9.570057949176055, 1.9697089182513596, 'UPHENO:0002768', 'abnormal strand of hair'),
(451671, 'HP:0002217', 'Slow-growing hair', 'MP:0002938', 'white spotting', 0.40540540540540543, 9.570057949176055, 1.9697089182513596, 'UPHENO:0002768', 'abnormal strand of hair'),
(451672, 'HP:0002217', 'Slow-growing hair', 'MP:0005171', 'absent coat pigmentation', 0.40540540540540543, 9.570057949176055, 1.9697089182513596, 'UPHENO:0002768', 'abnormal strand of hair'),
(451673, 'HP:0002217', 'Slow-growing hair', 'MP:0001511', 'disheveled coat', 0.42857142857142855, 9.570057949176055, 2.0252045345568774, 'UPHENO:0002768', 'abnormal strand of hair'),
(451674, 'HP:0002217', 'Slow-growing hair', 'MP:0013115', 'focal hair loss in abdominal region', 0.40540540540540543, 9.570057949176055, 1.9697089182513596, 'UPHENO:0002768', 'abnormal strand of hair'),
(451675, 'HP:0002217', 'Slow-growing hair', 'MP:0008899', 'plush coat', 0.42857142857142855, 9.570057949176055, 2.0252045345568774, 'UPHENO:0002768', 'abnormal strand of hair'),
(451676, 'HP:0002217', 'Slow-growing hair', 'MP:0000370', 'head blaze', 0.40540540540540543, 9.570057949176055, 1.9697089182513596, 'UPHENO:0002768', 'abnormal strand of hair'),
(451677, 'HP:0002217', 'Slow-growing hair', 'MP:0009932', 'skin fibrosis', 0.42857142857142855, 6.904974582545727, 1.7202542896592428, 'UPHENO:0003811', 'abnormal skin of body'),
(451678, 'HP:0002217', 'Slow-growing hair', 'MP:0005114', 'premature hair loss', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(451679, 'HP:0002217', 'Slow-growing hair', 'MP:0012017', 'grizzled coat color', 0.40540540540540543, 9.570057949176055, 1.9697089182513596, 'UPHENO:0002768', 'abnormal strand of hair'),
(451680, 'HP:0002217', 'Slow-growing hair', 'MP:0008812', 'abnormal rostrocaudal coat patterning', 0.40540540540540543, 9.570057949176055, 1.9697089182513596, 'UPHENO:0002768', 'abnormal strand of hair'),
(451681, 'HP:0002217', 'Slow-growing hair', 'MP:0010142', 'disorganized hair shaft', 0.4090909090909091, 9.570057949176055, 1.9786418843441866, 'UPHENO:0002768', 'abnormal strand of hair'),
(451682, 'HP:0002217', 'Slow-growing hair', 'MP:0000372', 'irregular coat pigmentation', 0.40540540540540543, 9.570057949176055, 1.9697089182513596, 'UPHENO:0002768', 'abnormal strand of hair'),
(451683, 'HP:0002217', 'Slow-growing hair', 'MP:0000411', 'shiny fur', 0.42857142857142855, 9.570057949176055, 2.0252045345568774, 'UPHENO:0002768', 'abnormal strand of hair'),
(451684, 'HP:0002217', 'Slow-growing hair', 'MP:0000426', 'ectopic hair growth', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(451685, 'HP:0002217', 'Slow-growing hair', 'MP:0000407', 'abnormal duvet hair morphology', 0.4411764705882353, 9.570057949176055, 2.0547711282141323, 'UPHENO:0002768', 'abnormal strand of hair'),
(451686, 'HP:0002217', 'Slow-growing hair', 'MP:0002073', 'abnormal hair growth', 0.42857142857142855, 9.570057949176055, 2.0252045345568774, 'UPHENO:0002768', 'abnormal strand of hair'),
(451687, 'HP:0002217', 'Slow-growing hair', 'MP:0000418', 'focal hair loss', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(451688, 'HP:0002217', 'Slow-growing hair', 'MP:0004034', 'belly blaze', 0.40540540540540543, 9.570057949176055, 1.9697089182513596, 'UPHENO:0002768', 'abnormal strand of hair'),
(451689, 'HP:0002217', 'Slow-growing hair', 'MP:0011280', 'abnormal flank coat pigmentation', 0.40540540540540543, 9.570057949176055, 1.9697089182513596, 'UPHENO:0002768', 'abnormal strand of hair'),
(451690, 'HP:0002217', 'Slow-growing hair', 'MP:0009004', 'progressive hair loss', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(451691, 'HP:0002217', 'Slow-growing hair', 'MP:0000400', 'abnormal awl hair morphology', 0.4411764705882353, 9.570057949176055, 2.0547711282141323, 'UPHENO:0002768', 'abnormal strand of hair'),
(451692, 'HP:0002217', 'Slow-growing hair', 'MP:0000405', 'abnormal auchene hair morphology', 0.4411764705882353, 9.570057949176055, 2.0547711282141323, 'UPHENO:0002768', 'abnormal strand of hair'),
(451693, 'HP:0002217', 'Slow-growing hair', 'MP:0009933', 'abnormal tail hair pigmentation', 0.40540540540540543, 9.570057949176055, 1.9697089182513596, 'UPHENO:0002768', 'abnormal strand of hair'),
(451694, 'HP:0002217', 'Slow-growing hair', 'MP:0009928', 'abnormal pinna hair pigmentation', 0.40540540540540543, 9.570057949176055, 1.9697089182513596, 'UPHENO:0002768', 'abnormal strand of hair'),
(451695, 'HP:0002217', 'Slow-growing hair', 'MP:0000402', 'abnormal zigzag hair morphology', 0.4411764705882353, 9.570057949176055, 2.0547711282141323, 'UPHENO:0002768', 'abnormal strand of hair'),
(451696, 'HP:0002217', 'Slow-growing hair', 'MP:0020235', 'black belted', 0.40540540540540543, 9.570057949176055, 1.9697089182513596, 'UPHENO:0002768', 'abnormal strand of hair'),
(451697, 'HP:0002217', 'Slow-growing hair', 'MP:0000367', 'abnormal coat/ hair morphology', 0.46875, 9.570057949176055, 2.118009599524109, 'UPHENO:0002768', 'abnormal strand of hair'),
(451698, 'HP:0002879', 'Anisospondyly', 'MP:0021137', 'abnormal wedge-shaped vertebrae', 0.4318181818181818, 8.941811350726098, 1.9650029820923236, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(451699, 'HP:0002879', 'Anisospondyly', 'MP:0004703', 'abnormal vertebral column morphology', 0.4166666666666667, 8.557298718460714, 1.8882640526928336, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(451700, 'HP:0002879', 'Anisospondyly', 'MP:0004174', 'abnormal spine curvature', 0.40540540540540543, 8.557298718460714, 1.86257218816687, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(451701, 'HP:0002879', 'Anisospondyly', 'MP:0004707', 'enlarged lumbar vertebrae', 0.40425531914893614, 8.941811350726098, 1.9012561114582536, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(451702, 'HP:0002879', 'Anisospondyly', 'MP:0004669', 'enlarged vertebral body', 0.46511627906976744, 10.93472192593978, 2.255197812799514, 'UPHENO:0076707', 'abnormal bony vertebral centrum morphology'),
(451703, 'HP:0002879', 'Anisospondyly', 'MP:0003050', 'abnormal sacral vertebrae morphology', 0.41025641025641024, 8.941811350726098, 1.9153160120301067, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(451704, 'HP:0002879', 'Anisospondyly', 'MP:0031312', 'spondylolysis', 0.40540540540540543, 8.557298718460714, 1.86257218816687, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(451705, 'HP:0002879', 'Anisospondyly', 'MP:0004600', 'abnormal vertebral transverse process morphology', 0.40476190476190477, 8.941811350726098, 1.902447001716872, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(451706, 'HP:0002879', 'Anisospondyly', 'MP:0013972', 'occipital vertebra', 0.42105263157894735, 8.941811350726098, 1.9403538853275515, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(451707, 'HP:0002879', 'Anisospondyly', 'MP:0004687', 'split vertebrae', 0.40425531914893614, 8.941811350726098, 1.9012561114582536, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(451708, 'HP:0002879', 'Anisospondyly', 'MP:0004704', 'short vertebral column', 0.4090909090909091, 8.557298718460714, 1.8710192709049165, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(451709, 'HP:0002879', 'Anisospondyly', 'MP:0003049', 'abnormal lumbar vertebrae morphology', 0.40476190476190477, 8.941811350726098, 1.902447001716872, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(451710, 'HP:0002879', 'Anisospondyly', 'MP:0005225', 'abnormal vertebrae development', 0.41025641025641024, 8.941811350726098, 1.9153160120301067, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(451711, 'HP:0002879', 'Anisospondyly', 'MP:0008832', 'hemivertebra', 0.42105263157894735, 8.941811350726098, 1.9403538853275515, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(451712, 'HP:0002879', 'Anisospondyly', 'MP:0000141', 'abnormal vertebral body morphology', 0.4473684210526316, 10.93472192593978, 2.2117525364871335, 'UPHENO:0076707', 'abnormal bony vertebral centrum morphology'),
(451713, 'HP:0002879', 'Anisospondyly', 'MP:0004643', 'abnormal vertebrae number', 0.4146341463414634, 8.941811350726098, 1.9255078073471226, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(451714, 'HP:0002879', 'Anisospondyly', 'MP:0031313', 'spondylolisthesis', 0.40540540540540543, 8.557298718460714, 1.86257218816687, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(451715, 'HP:0002879', 'Anisospondyly', 'MP:0000459', 'abnormal presacral vertebrae morphology', 0.4358974358974359, 8.941811350726098, 1.974262556009229, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(451716, 'HP:0002879', 'Anisospondyly', 'MP:0004602', 'abnormal vertebral articular process morphology', 0.40476190476190477, 8.941811350726098, 1.902447001716872, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(451717, 'HP:0002879', 'Anisospondyly', 'MP:0004705', 'elongated vertebral body', 0.4166666666666667, 10.93472192593978, 2.134510280089614, 'UPHENO:0076707', 'abnormal bony vertebral centrum morphology'),
(451718, 'HP:0002879', 'Anisospondyly', 'MP:0004670', 'small vertebral body', 0.45454545454545453, 10.93472192593978, 2.22942327702804, 'UPHENO:0076707', 'abnormal bony vertebral centrum morphology'),
(451719, 'HP:0002879', 'Anisospondyly', 'MP:0004610', 'small vertebrae', 0.4523809523809524, 8.941811350726098, 2.011244673045098, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(451720, 'HP:0002879', 'Anisospondyly', 'MP:0000137', 'abnormal vertebrae morphology', 0.43243243243243246, 8.941811350726098, 1.9664000693517127, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(451721, 'HP:0002879', 'Anisospondyly', 'MP:0005227', 'abnormal vertebral body development', 0.4146341463414634, 10.93472192593978, 2.129297792992639, 'UPHENO:0076707', 'abnormal bony vertebral centrum morphology'),
(451722, 'HP:0002879', 'Anisospondyly', 'MP:0013612', 'enlarged caudal vertebrae', 0.40425531914893614, 8.941811350726098, 1.9012561114582536, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(451723, 'HP:0002879', 'Anisospondyly', 'MP:0003036', 'vertebral transformation', 0.42105263157894735, 8.941811350726098, 1.9403538853275515, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(451724, 'HP:0002879', 'Anisospondyly', 'MP:0021136', 'abnormal vertebrae shape', 0.4418604651162791, 8.941811350726098, 1.9877205342838962, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(451725, 'HP:0002879', 'Anisospondyly', 'MP:0004706', 'short vertebral body', 0.40816326530612246, 10.93472192593978, 2.112617288224735, 'UPHENO:0076707', 'abnormal bony vertebral centrum morphology'),
(451726, 'HP:0002879', 'Anisospondyly', 'MP:0008771', 'elongated vertebral column', 0.4090909090909091, 8.557298718460714, 1.8710192709049165, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(451727, 'HP:0002879', 'Anisospondyly', 'MP:0004626', 'vertebral compression', 0.4222222222222222, 8.941811350726098, 1.943046952390874, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(451728, 'HP:0002879', 'Anisospondyly', 'MP:0004657', 'small sacral vertebrae', 0.41304347826086957, 8.941811350726098, 1.9218108289466038, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(451729, 'HP:0012273', 'Increased carotid artery intimal medial thickness', 'MP:0011655', 'abnormal systemic artery morphology', 0.42105263157894735, 9.101997348968142, 1.9576567463188328, 'UPHENO:0087334', 'abnormal systemic artery morphology'),
(451730, 'HP:0012273', 'Increased carotid artery intimal medial thickness', 'MP:0012562', 'blood vessel degeneration', 0.425, 6.970522647367627, 1.7211833502364706, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(451731, 'HP:0012273', 'Increased carotid artery intimal medial thickness', 'MP:0020841', 'abnormal supporting cell of carotid body morphology', 0.40816326530612246, 11.249595263293193, 2.1428185961574155, 'UPHENO:0076798', 'abnormal common carotid artery plus branches morphology'),
(451732, 'HP:0012273', 'Increased carotid artery intimal medial thickness', 'MP:0000265', 'blood vessel atresia', 0.425, 6.970522647367627, 1.7211833502364706, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(451733, 'HP:0012273', 'Increased carotid artery intimal medial thickness', 'MP:0003437', 'abnormal carotid body morphology', 0.40476190476190477, 11.249595263293193, 2.1338715065746237, 'UPHENO:0076798', 'abnormal common carotid artery plus branches morphology'),
(451734, 'HP:0012273', 'Increased carotid artery intimal medial thickness', 'MP:0013982', 'inverse situs of great intrathoracic arteries', 0.41025641025641024, 9.101997348968142, 1.9323956009448564, 'UPHENO:0087334', 'abnormal systemic artery morphology'),
(451735, 'HP:0012273', 'Increased carotid artery intimal medial thickness', 'MP:0020327', 'abnormal capillary branching pattern', 0.40476190476190477, 6.970522647367627, 1.6797029570535724, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(451736, 'HP:0012273', 'Increased carotid artery intimal medial thickness', 'MP:0002191', 'abnormal artery morphology', 0.40540540540540543, 8.259895016664046, 1.8299196943682463, 'UPHENO:0086797', 'abnormal artery morphology'),
(451737, 'HP:0012273', 'Increased carotid artery intimal medial thickness', 'MP:0012729', 'abnormal common carotid artery morphology', 0.40476190476190477, 11.249595263293193, 2.1338715065746237, 'UPHENO:0076798', 'abnormal common carotid artery plus branches morphology'),
(451738, 'HP:0012273', 'Increased carotid artery intimal medial thickness', 'MP:0004938', 'dilated vasculature', 0.40476190476190477, 6.970522647367627, 1.6797029570535724, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(451739, 'HP:0012273', 'Increased carotid artery intimal medial thickness', 'MP:0006133', 'calcified artery', 0.43902439024390244, 8.259895016664046, 1.9042834277411493, 'UPHENO:0086797', 'abnormal artery morphology'),
(451740, 'HP:0012273', 'Increased carotid artery intimal medial thickness', 'MP:0006134', 'artery occlusion', 0.4186046511627907, 8.259895016664046, 1.8594704816403853, 'UPHENO:0086797', 'abnormal artery morphology'),
(451741, 'HP:0012273', 'Increased carotid artery intimal medial thickness', 'MP:0010522', 'calcified aorta', 0.40425531914893614, 9.101997348968142, 1.9182103229833498, 'UPHENO:0087334', 'abnormal systemic artery morphology'),
(451742, 'HP:0005156', 'Hypoplastic left atrium', 'MP:0000287', 'heart valve hypoplasia', 0.4074074074074074, 8.202005804774931, 1.8279928666337462, 'UPHENO:0081790', 'anatomical entity hypoplasia in independent continuant'),
(451743, 'HP:0005156', 'Hypoplastic left atrium', 'MP:0004055', 'atrium hypoplasia', 0.52, 15.022184767190119, 2.7949125351142676, 'UPHENO:0081173', 'cardiac atrium hypoplasia'),
(451744, 'HP:0005156', 'Hypoplastic left atrium', 'MP:0010647', 'left atrium hypoplasia', 0.5576923076923077, 16.607147267911277, 3.0433005576228327, 'UPHENO:0081211', 'left cardiac atrium hypoplasia'),
(451745, 'HP:0005156', 'Hypoplastic left atrium', 'MP:0010501', 'atrium myocardium hypoplasia', 0.4264705882352941, 15.022184767190119, 2.5311104231626964, 'UPHENO:0081173', 'cardiac atrium hypoplasia'),
(451746, 'HP:0005156', 'Hypoplastic left atrium', 'MP:0000279', 'ventricular hypoplasia', 0.42857142857142855, 13.104646927382092, 2.369868615470555, 'UPHENO:0069463', 'decreased size of the heart'),
(451747, 'HP:0005156', 'Hypoplastic left atrium', 'MP:0010648', 'right atrium hypoplasia', 0.4727272727272727, 15.022184767190119, 2.664844542445012, 'UPHENO:0081173', 'cardiac atrium hypoplasia'),
(451748, 'HP:0005156', 'Hypoplastic left atrium', 'MP:0002740', 'heart hypoplasia', 0.47058823529411764, 14.192109768632433, 2.5843064623068885, 'UPHENO:0081262', 'heart hypoplasia'),
(451749, 'HP:0002557', 'Hypoplastic nipples', 'MP:0000071', 'axial skeleton hypoplasia', 0.41509433962264153, 8.202005804774931, 1.8451574954767742, 'UPHENO:0081790', 'anatomical entity hypoplasia in independent continuant'),
(451750, 'HP:0003562', 'Abnormal metaphyseal vascular invasion', 'MP:0002115', 'abnormal limb bone morphology', 0.40476190476190477, 6.179485229767373, 1.5815246479421996, 'UPHENO:0076727', 'abnormal limb bone morphology'),
(451751, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0004625', 'abnormal rib joint morphology', 0.41935483870967744, 8.414032639097075, 1.8784209592810968, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(451752, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0010971', 'abnormal periosteum morphology', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451753, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0030804', 'abnormal synovial joint morphology', 0.48148148148148145, 8.414032639097075, 2.01275952371514, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(451754, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0000130', 'abnormal trabecular bone morphology', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451755, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0002937', 'synovial hyperemia', 0.4642857142857143, 8.414032639097075, 1.9764906156788347, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(451756, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0010924', 'abnormal osteoid morphology', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451757, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0010123', 'increased bone mineral content', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451758, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0030222', 'hyperostosis', 0.48, 4.825104621810128, 1.5218574895399573, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451759, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0002114', 'abnormal axial skeleton morphology', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451760, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0030805', 'abnormal limb joint morphology', 0.41935483870967744, 8.414032639097075, 1.8784209592810968, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(451761, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0008150', 'decreased diameter of long bones', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451762, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0009918', 'abnormal stylohyoid ligament morphology', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451763, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0030866', 'abnormal synovial joint membrane morphology', 0.4482758620689655, 8.414032639097075, 1.9421142434902365, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(451764, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0009807', 'abnormal pelvic ligament morphology', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451765, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0013304', 'osteophytes', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451766, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0011642', 'abnormal bone collagen fibril morphology', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451767, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0031348', 'bone fibrous dysplasia', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451768, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0010874', 'abnormal bone volume', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451769, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0005508', 'abnormal skeleton morphology', 0.5, 4.825104621810128, 1.5532392960857848, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451770, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0000163', 'abnormal cartilage morphology', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451771, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0006431', 'abnormal fibrocartilage morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451772, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0004703', 'abnormal vertebral column morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451773, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0012070', 'abnormal susceptibility to osteoporosis', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451774, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0013941', 'abnormal enthesis morphology', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451775, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0003200', 'calcified joint', 0.40625, 8.414032639097075, 1.8488376780110218, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(451776, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0014024', 'increased subchondral bone mineral content', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451777, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0003797', 'abnormal compact bone morphology', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451778, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0004624', 'abnormal thoracic cage morphology', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451779, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0030819', 'abnormal pelvic girdle joint morphology', 0.41935483870967744, 8.414032639097075, 1.8784209592810968, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(451780, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0003795', 'abnormal bone structure', 0.48, 4.825104621810128, 1.5218574895399573, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451781, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0030486', 'abnormal osteocyte canaliculus morphology', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451782, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0010122', 'abnormal bone mineral content', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451783, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0010966', 'abnormal compact bone area', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451784, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0012071', 'increased susceptibility to osteoporosis', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451785, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0002932', 'abnormal joint morphology', 0.52, 8.414032639097075, 2.091721055095655, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(451786, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0010970', 'abnormal compact bone lamellar structure', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451787, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0003723', 'abnormal long bone morphology', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451788, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0010925', 'abnormal osteoid volume', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451789, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0009250', 'abnormal appendicular skeleton morphology', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451790, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0000997', 'abnormal synovial joint capsule morphology', 0.4482758620689655, 8.414032639097075, 1.9421142434902365, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(451791, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0010119', 'abnormal bone mineral density', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451792, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0030875', 'abnormal cartilaginous joint morphology', 0.48148148148148145, 8.414032639097075, 2.01275952371514, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(451793, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0030818', 'abnormal girdle joint morphology', 0.48148148148148145, 8.414032639097075, 2.01275952371514, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(451794, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0030879', 'abnormal syndesmosis morphology', 0.41935483870967744, 8.414032639097075, 1.8784209592810968, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(451795, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0002113', 'abnormal skeleton development', 0.48, 4.825104621810128, 1.5218574895399573, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451796, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0031350', 'polyostotic fibrous dysplasia', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451797, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0004509', 'abnormal pelvic girdle bone morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451798, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0030820', 'abnormal pectoral girdle joint morphology', 0.40625, 8.414032639097075, 1.8488376780110218, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(451799, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0006430', 'abnormal elastic cartilage morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451800, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0030877', 'abnormal symphysis morphology', 0.41935483870967744, 8.414032639097075, 1.8784209592810968, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(451801, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0004508', 'abnormal pectoral girdle bone morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451802, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0030865', 'abnormal synovial joint cavity morphology', 0.4482758620689655, 8.414032639097075, 1.9421142434902365, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(451803, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0008151', 'increased diameter of long bones', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451804, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0010124', 'decreased bone mineral content', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451805, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0012072', 'decreased susceptibility to osteoporosis', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451806, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0000164', 'abnormal cartilage development', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451807, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0010931', 'abnormal trabecular bone connectivity density', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451808, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0014025', 'decreased subchondral bone mineral content', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451809, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0030795', 'joint dislocation', 0.41935483870967744, 8.414032639097075, 1.8784209592810968, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(451810, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0030878', 'abnormal fibrous joint morphology', 0.48148148148148145, 8.414032639097075, 2.01275952371514, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(451811, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0030485', 'abnormal osteocyte lacunocanalicular system morphology', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451812, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0006429', 'abnormal hyaline cartilage morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451813, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0005504', 'abnormal ligament morphology', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451814, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0002657', 'chondrodystrophy', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451815, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0030484', 'abnormal osteocyte lacuna morphology', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451816, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0013629', 'abnormal bone trabecular spacing', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451817, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0031349', 'monostotic fibrous dysplasia', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451818, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0000566', 'synostosis', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451819, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0005422', 'osteosclerosis', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451820, 'HP:0040312', 'Temporomandibular arthritis', 'MP:0009877', 'exostosis', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(451821, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0011994', 'increased nerve conduction velocity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451822, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0001650', 'abnormal seizure response to electrical stimulation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451823, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451824, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0002195', 'psychomotor seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451825, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0014252', 'abnormal paired-pulse ratio', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451826, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0003474', 'abnormal summary potential intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451827, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0021010', 'impaired synaptic physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451828, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451829, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(451830, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0005645', 'abnormal hypothalamus physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451831, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0003635', 'abnormal synaptic transmission', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451832, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451833, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0003216', 'absence seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451834, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0010050', 'hypermyelination', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451835, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0003633', 'abnormal nervous system physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451836, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0004994', 'abnormal brain wave pattern', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451837, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0003483', 'decreased nerve fiber response threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451838, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451839, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0003472', 'increased summary potential threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451840, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0004183', 'abnormal sympathetic nervous system physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451841, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0003476', 'decreased summary potential intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451842, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0003444', 'abnormal neurotransmitter uptake', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451843, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0013438', 'dysmyelination', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451844, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0003412', 'abnormal afterhyperpolarization', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451845, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0001985', 'abnormal gustatory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(451846, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0021015', 'increased tau protein phosphorylation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451847, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0011399', 'increased endoneurial fluid pressure', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451848, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0008840', 'abnormal spike wave discharge', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451849, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0003480', 'increased nerve fiber response intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451850, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0003465', 'increased single cell response threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451851, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451852, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0009358', 'environmentally induced seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451853, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0003466', 'decreased single cell response threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451854, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0014120', 'focal seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451855, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(451856, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451857, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0008814', 'decreased nerve conduction velocity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451858, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451859, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0003477', 'abnormal nerve fiber response', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451860, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0003471', 'abnormal summary potential threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451861, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0011397', 'endoneurial edema', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451862, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0000921', 'demyelination', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451863, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0021009', 'abnormal synaptic physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451864, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451865, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451866, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0001752', 'abnormal hypothalamus secretion', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451867, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0003473', 'decreased summary potential threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451868, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0002193', 'minimal clonic seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451869, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0004807', 'abnormal paired-pulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451870, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451871, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0003482', 'increased nerve fiber response threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451872, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451873, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451874, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0012006', 'abnormal hippocampus physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451875, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0003475', 'increased summary potential intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451876, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0003470', 'abnormal summary potential', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451877, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0005403', 'abnormal nerve conduction', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451878, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451879, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451880, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0002634', 'abnormal sensorimotor gating', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451881, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451882, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0002918', 'abnormal paired-pulse facilitation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451883, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0012011', 'febrile seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451884, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0002206', 'abnormal CNS synaptic transmission', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451885, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451886, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0003467', 'abnormal single cell response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451887, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0003468', 'increased single cell response intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451888, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0003469', 'decreased single cell response intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451889, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451890, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0000920', 'abnormal myelination', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451891, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451892, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0003880', 'abnormal central pattern generator function', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451893, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0001499', 'abnormal kindling response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451894, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451895, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451896, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0002164', 'abnormal gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(451897, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0020371', 'abnormal glymphatic system physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451898, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451899, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0003996', 'clonic seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451900, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451901, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0002913', 'abnormal PNS synaptic transmission', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451902, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0021016', 'decreased tau protein phosphorylation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451903, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0002826', 'tonic seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451904, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0013806', 'encephalopathy', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451905, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0003484', 'abnormal channel response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451906, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0010680', 'abnormal skin adnexa physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(451907, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0004513', 'avnosmia', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451908, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451909, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0006080', 'brain ischemia', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451910, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0005445', 'abnormal neurotransmitter secretion', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451911, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0004811', 'abnormal neuron physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451912, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0006060', 'increased cerebral infarct size', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451913, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(451914, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0002194', 'maximal tonic hindlimb extension seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451915, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0002204', 'abnormal synaptic neurotransmitter level', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451916, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451917, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0003997', 'tonic-clonic seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451918, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0003464', 'abnormal single cell response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451919, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0003463', 'abnormal single cell response', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451920, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0002578', 'impaired ability to fire action potentials', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451921, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0001983', 'abnormal olfactory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(451922, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0004859', 'abnormal synaptic plasticity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451923, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0001912', 'increased cerebrospinal fluid production', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451924, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0005402', 'abnormal action potential', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451925, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0000947', 'convulsive seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451926, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451927, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0006058', 'decreased cerebral infarct size', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451928, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451929, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0000951', 'sporadic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451930, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0000948', 'nonconvulsive seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451931, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0002064', 'seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451932, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0003481', 'decreased nerve fiber response intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451933, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0003889', 'enhanced sensorimotor gating', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451934, 'HP:0011215', 'Hemihypsarrhythmia', 'MP:0002635', 'reduced sensorimotor gating', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451935, 'HP:0010748', 'Ectopic lacrimal punctum', 'MP:0006198', 'enophthalmos', 0.40384615384615385, 6.679863125803252, 1.6424484867338733, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(451936, 'HP:0010748', 'Ectopic lacrimal punctum', 'MP:0001299', 'abnormal eye distance/ position', 0.4117647058823529, 6.679863125803252, 1.6584727538704853, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(451937, 'HP:0010748', 'Ectopic lacrimal punctum', 'MP:0008969', 'abnormal nasolacrimal duct morphology', 0.41509433962264153, 12.607147267911277, 2.287609116457403, 'UPHENO:0076731', 'abnormal lacrimal drainage system morphology'),
(451938, 'HP:0010748', 'Ectopic lacrimal punctum', 'MP:0008968', 'abnormal lacrimal apparatus morphology', 0.4117647058823529, 11.799792345853673, 2.2042545281258414, 'UPHENO:0088074', 'abnormal lacrimal apparatus morphology'),
(451939, 'HP:0010748', 'Ectopic lacrimal punctum', 'MP:0013449', 'abnormal lacrimal lake morphology', 0.40384615384615385, 11.799792345853673, 2.1829568834624955, 'UPHENO:0088074', 'abnormal lacrimal apparatus morphology'),
(451940, 'HP:0010748', 'Ectopic lacrimal punctum', 'MP:0013451', 'nasolacrimal duct obstruction', 0.43859649122807015, 12.607147267911277, 2.3514783767029277, 'UPHENO:0076731', 'abnormal lacrimal drainage system morphology'),
(451941, 'HP:0010748', 'Ectopic lacrimal punctum', 'MP:0005254', 'strabismus', 0.40384615384615385, 6.679863125803252, 1.6424484867338733, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(451942, 'HP:5200055', 'Reduced co-speech gestures', 'MP:0003633', 'abnormal nervous system physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(451943, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0011925', 'abnormal heart echocardiography feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(451944, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(451945, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(451946, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(451947, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(451948, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008558', 'abnormal interferon-beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(451949, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0013636', 'abnormal bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(451950, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(451951, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0030132', 'periodontium inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(451952, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(451953, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(451954, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0005001', 'abnormal clonal deletion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(451955, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0010994', 'aerophagia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(451956, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(451957, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0001664', 'abnormal digestion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(451958, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(451959, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(451960, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0005620', 'abnormal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(451961, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(451962, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0004752', 'decreased length of allograft survival', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(451963, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(451964, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0010211', 'abnormal acute phase protein level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(451965, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0011043', 'abnormal lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(451966, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008699', 'increased interleukin-4 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(451967, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0031221', 'abnormal CXCL10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(451968, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0031090', 'ageusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(451969, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008660', 'increased interleukin-10 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(451970, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(451971, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020412', 'abnormal amnion physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(451972, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(451973, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0031223', 'increased CXCL10 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(451974, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(451975, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(451976, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0003298', 'choking', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(451977, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(451978, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0001846', 'increased inflammatory response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(451979, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020386', 'adipose tissue inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(451980, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008703', 'decreased interleukin-5 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(451981, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008711', 'increased interleukin-9 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(451982, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0003865', 'lymph node inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(451983, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0030990', 'nerve inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(451984, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0011763', 'urethritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(451985, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0013806', 'encephalopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(451986, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0005044', 'sepsis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(451987, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0000427', 'abnormal hair cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(451988, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(451989, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008652', 'decreased interleukin-1 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(451990, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(451991, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(451992, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(451993, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(451994, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0005666', 'abnormal adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(451995, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0001861', 'lung inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(451996, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(451997, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(451998, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(451999, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452000, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0002128', 'abnormal blood circulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452001, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452002, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008563', 'decreased interferon-alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452003, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0004558', 'delayed allantois development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452004, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0009057', 'increased interleukin-21 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452005, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452006, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0001835', 'abnormal antigen presentation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452007, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0002499', 'chronic inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452008, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452009, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0002498', 'abnormal acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452010, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452011, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452012, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0009697', 'abnormal copulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452013, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452014, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452015, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008555', 'abnormal interferon secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452016, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452017, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452018, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0000423', 'delayed hair regrowth', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452019, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008748', 'abnormal central T cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452020, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0031053', 'pleuritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452021, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452022, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0011717', 'increased interleukin-8 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452023, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008747', 'abnormal T cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452024, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452025, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0013559', 'abnormal exocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452026, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0001866', 'nasal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452027, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452028, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0003633', 'abnormal nervous system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452029, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0005043', 'defective assembly of class II molecules', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452030, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452031, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452032, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452033, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452034, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0031098', 'abnormal sputum production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452035, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452036, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452037, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452038, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0005190', 'osteomyelitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452039, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008690', 'increased interleukin-23 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452040, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008691', 'decreased interleukin-23 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452041, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0003077', 'abnormal cell cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452042, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0005621', 'abnormal cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452043, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452044, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008775', 'abnormal heart ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452045, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020142', 'increased anti-sperm antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452046, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452047, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0009058', 'decreased interleukin-21 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452048, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452049, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452050, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0010680', 'abnormal skin adnexa physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452051, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0003186', 'abnormal redox activity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452052, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452053, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452054, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0001872', 'sinus inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452055, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0002473', 'impaired complement classical pathway', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452056, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0001919', 'abnormal reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452057, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452058, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452059, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0001800', 'abnormal humoral immune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452060, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0030153', 'dental pulp inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452061, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0031091', 'hypogeusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452062, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452063, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452064, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008672', 'increased interleukin-13 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452065, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008568', 'abnormal interleukin secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452066, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0031089', 'sneezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452067, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0030988', 'dysosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452068, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0002421', 'abnormal cell-mediated immunity', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452069, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008661', 'decreased interleukin-10 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452070, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452071, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008705', 'increased interleukin-6 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452072, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0004796', 'increased anti-histone antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452073, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452074, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008651', 'increased interleukin-1 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452075, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020000', 'abnormal response to antigen', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452076, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452077, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008664', 'decreased interleukin-12 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452078, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0012553', 'decreased serum complement activity', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452079, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452080, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452081, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008693', 'increased interleukin-23a secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452082, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0000313', 'abnormal cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452083, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0011762', 'renal/urinary system inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452084, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008712', 'decreased interleukin-9 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452085, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020154', 'impaired humoral immune response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452086, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0002164', 'abnormal gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452087, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020001', 'decreased response to antigen', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452088, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0002500', 'granulomatous inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452089, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452090, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0002161', 'abnormal fertility/fecundity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452091, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452092, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008702', 'increased interleukin-5 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452093, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0002254', 'reproductive system inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452094, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008567', 'decreased interferon-gamma secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452095, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0002420', 'abnormal adaptive immunity', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452096, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008861', 'abnormal hair shedding', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452097, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452098, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0013971', 'blood in lymph vessels', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452099, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020155', 'enhanced humoral immune response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452100, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0004512', 'anosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452101, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008681', 'increased interleukin-17 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452102, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452103, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020002', 'increased response to antigen', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452104, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0001847', 'brain inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452105, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452106, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452107, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0001943', 'abnormal respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452108, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0013498', 'trachea inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452109, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452110, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452111, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452112, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008566', 'increased interferon-gamma secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452113, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0003777', 'lip inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452114, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0011046', 'abnormal lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452115, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452116, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0002472', 'impaired complement alternative pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452117, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008706', 'decreased interleukin-6 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452118, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0004947', 'skin inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452119, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452120, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0003762', 'abnormal immune organ physiology', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452121, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452122, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008685', 'decreased interleukin-18 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452123, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452124, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0013136', 'genital discharge', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452125, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452126, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008562', 'increased interferon-alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452127, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0031111', 'meningoencephalitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452128, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452129, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0004751', 'increased length of allograft survival', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452130, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0031088', 'coughing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452131, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008744', 'abnormal B cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452132, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452133, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452134, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0001533', 'abnormal skeleton physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452135, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0006082', 'CNS inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452136, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0001876', 'decreased inflammatory response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452137, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452138, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0003303', 'peritoneal inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452139, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0009062', 'impaired lectin complement pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452140, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452141, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008709', 'decreased interleukin-7 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452142, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452143, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0012382', 'abnormal blood cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452144, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0004213', 'abnormal umami taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452145, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0004085', 'abnormal heartbeat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452146, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452147, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0001663', 'abnormal digestive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452148, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0001793', 'abnormal susceptibility to infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452149, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0002723', 'abnormal immune serum protein physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452150, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0030987', 'spinal cord inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452151, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020846', 'abnormal cell motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452152, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0003009', 'abnormal cytokine secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452153, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0004510', 'myositis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452154, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0004212', 'abnormal salty taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452155, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452156, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452157, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452158, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0001845', 'abnormal inflammatory response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452159, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008697', 'decreased interleukin-3 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452160, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0030129', 'tongue inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452161, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0002419', 'abnormal innate immunity', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452162, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0003880', 'abnormal central pattern generator function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452163, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452164, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0010822', 'pneumothorax', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452165, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452166, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008678', 'increased interleukin-16 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452167, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452168, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0002418', 'increased susceptibility to viral infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452169, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452170, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008666', 'increased interleukin-12a secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452171, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0012685', 'abnormal primitive streak elongation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452172, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008679', 'decreased interleukin-16 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452173, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0001873', 'stomach inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452174, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008544', 'impaired olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452175, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452176, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0005410', 'abnormal fertilization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452177, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0004036', 'abnormal muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452178, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452179, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008713', 'abnormal cytokine level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452180, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452181, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0001542', 'abnormal bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452182, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0001986', 'abnormal taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452183, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0003278', 'esophageal inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452184, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0001819', 'abnormal immune cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452185, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452186, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452187, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008271', 'abnormal bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452188, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0001864', 'vascular inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452189, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452190, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0003767', 'palate inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452191, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008564', 'increased interferon-beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452192, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452193, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0003566', 'abnormal cell adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452194, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0011718', 'decreased interleukin-8 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452195, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008688', 'decreased interleukin-2 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452196, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452197, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0002634', 'abnormal sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452198, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452199, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452200, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0010377', 'abnormal gut flora balance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452201, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452202, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452203, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452204, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452205, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452206, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452207, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0000350', 'abnormal cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452208, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0031402', 'decreased muscle fatigability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452209, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452210, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452211, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0001947', 'abnormal mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452212, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0010695', 'abnormal blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452213, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008663', 'increased interleukin-12 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452214, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008687', 'increased interleukin-2 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452215, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452216, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0003868', 'abnormal feces composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452217, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0003746', 'stomatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452218, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452219, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0002406', 'increased susceptibility to infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452220, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452221, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452222, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0005364', 'increased susceptibility to prion infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452223, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452224, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452225, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008669', 'increased interleukin-12b secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452226, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452227, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0002133', 'abnormal respiratory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452228, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008004', 'abnormal stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452229, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452230, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0005671', 'abnormal response to transplant', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452231, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0005076', 'abnormal cell differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452232, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452233, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452234, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452235, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452236, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0002405', 'respiratory system inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452237, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452238, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008682', 'decreased interleukin-17 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452239, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0003725', 'increased autoantibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452240, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0006080', 'brain ischemia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452241, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452242, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0001985', 'abnormal gustatory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452243, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452244, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0004211', 'abnormal sour taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452245, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0001983', 'abnormal olfactory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452246, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0013942', 'enthesitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452247, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0031302', 'syncope', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452248, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452249, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0002471', 'abnormal complement pathway', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452250, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008700', 'decreased interleukin-4 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452251, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452252, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008696', 'increased interleukin-3 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452253, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452254, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0005005', 'abnormal self tolerance', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452255, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0005501', 'abnormal skin physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452256, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452257, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452258, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452259, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452260, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008670', 'decreased interleukin-12b secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452261, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0003875', 'abnormal hair follicle regression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452262, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0031066', 'cytokine storm', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452263, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0009562', 'abnormal odor adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452264, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0004145', 'abnormal muscle electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452265, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452266, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0031222', 'decreased CXCL10 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452267, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452268, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452269, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008673', 'decreased interleukin-13 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452270, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0005087', 'decreased acute inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452271, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0002998', 'abnormal bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452272, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452273, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0005000', 'abnormal immune tolerance', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452274, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0011764', 'ureteritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452275, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452276, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0005025', 'abnormal response to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452277, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0004142', 'abnormal muscle tone', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452278, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0003925', 'abnormal cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452279, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0001984', 'abnormal olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452280, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0012554', 'increased serum complement activity', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452281, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452282, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0031092', 'dysgeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452283, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452284, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452285, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0001837', 'defective assembly of class I molecules', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452286, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0011082', 'abnormal gastrointestinal motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452287, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0031102', 'rhinorrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452288, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452289, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452290, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008675', 'increased interleukin-15 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452291, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0010950', 'abnormal lung hysteresivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452292, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452293, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452294, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452295, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452296, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452297, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008708', 'increased interleukin-7 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452298, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0002409', 'decreased susceptibility to infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452299, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0010368', 'abnormal lymphatic system physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452300, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0001790', 'abnormal immune system physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452301, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452302, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0012565', 'perivasculitis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452303, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008676', 'decreased interleukin-15 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452304, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0001844', 'autoimmune response', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452305, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008565', 'decreased interferon-beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452306, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0001756', 'abnormal urination', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452307, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008737', 'abnormal spleen physiology', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452308, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452309, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452310, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452311, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452312, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0003726', 'decreased autoantibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452313, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0002106', 'abnormal muscle physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452314, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452315, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008684', 'increased interleukin-18 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452316, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452317, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452318, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0031110', 'meningitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452319, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0009046', 'muscle twitch', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452320, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452321, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0031095', 'pharyngitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452322, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0005088', 'increased acute inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452323, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0008722', 'abnormal chemokine secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452324, 'HP:0030356', 'Increased circulating interferon-gamma concentration', 'MP:0000751', 'myopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452325, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0010149', 'abnormal synaptic dopamine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452326, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0011399', 'increased endoneurial fluid pressure', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452327, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0011987', 'abnormal GABAergic neuron physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452328, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0001986', 'abnormal taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452329, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0000427', 'abnormal hair cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452330, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0013596', 'abnormal vomeronasal organ physiology', 0.4166666666666667, 7.291997705654976, 1.7430812882238855, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452331, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0005446', 'abnormal synaptic epinephrine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452332, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0008840', 'abnormal spike wave discharge', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452333, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0001900', 'impaired synaptic plasticity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452334, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0003477', 'abnormal nerve fiber response', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452335, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0014252', 'abnormal paired-pulse ratio', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452336, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0005445', 'abnormal neurotransmitter secretion', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452337, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0001650', 'abnormal seizure response to electrical stimulation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452338, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0003464', 'abnormal single cell response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452339, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0003468', 'increased single cell response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452340, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0013438', 'dysmyelination', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452341, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0003219', 'increased spike-wave discharge type II', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452342, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0002913', 'abnormal PNS synaptic transmission', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452343, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0004753', 'abnormal miniature excitatory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452344, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0002207', 'abnormal long-term potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452345, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0008814', 'decreased nerve conduction velocity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452346, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0001790', 'abnormal immune system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452347, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0002193', 'minimal clonic seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452348, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0005645', 'abnormal hypothalamus physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452349, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0000951', 'sporadic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452350, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0003471', 'abnormal summary potential threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452351, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0009475', 'abnormal nicotine-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452352, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452353, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0021010', 'impaired synaptic physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452354, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452355, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0010746', 'abnormal pre-Botzinger complex physiology', 0.4166666666666667, 7.291997705654976, 1.7430812882238855, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452356, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0003486', 'abnormal channel response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452357, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0002164', 'abnormal gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452358, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0010680', 'abnormal skin adnexa physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452359, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0002918', 'abnormal paired-pulse facilitation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452360, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0004994', 'abnormal brain wave pattern', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452361, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0020424', 'increased kindling response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452362, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452363, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452364, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0003472', 'increased summary potential threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452365, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0002945', 'abnormal inhibitory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452366, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0002635', 'reduced sensorimotor gating', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452367, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0000948', 'nonconvulsive seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452368, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0012006', 'abnormal hippocampus physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452369, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0004768', 'abnormal axonal transport', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452370, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0004494', 'abnormal synaptic glutamate release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452371, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452372, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0003997', 'tonic-clonic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452373, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0001752', 'abnormal hypothalamus secretion', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452374, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0001500', 'decreased kindling response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452375, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0006080', 'brain ischemia', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452376, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0006060', 'increased cerebral infarct size', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452377, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0003481', 'decreased nerve fiber response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452378, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0021016', 'decreased tau protein phosphorylation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452379, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0014120', 'focal seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452380, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452381, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0003466', 'decreased single cell response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452382, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0003473', 'decreased summary potential threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452383, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0003218', 'decreased spike-wave discharge type I', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452384, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452385, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0003633', 'abnormal nervous system physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452386, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0002206', 'abnormal CNS synaptic transmission', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452387, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0002920', 'decreased paired-pulse facilitation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452388, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0003217', 'increased spike-wave discharge type I', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452389, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0001496', 'audiogenic seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452390, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0002914', 'abnormal endplate potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452391, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0011397', 'endoneurial edema', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452392, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0004183', 'abnormal sympathetic nervous system physiology', 0.46875, 7.291997705654976, 1.8488168985937385, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452393, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0020371', 'abnormal glymphatic system physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452394, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0013806', 'encephalopathy', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452395, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452396, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452397, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452398, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0021015', 'increased tau protein phosphorylation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452399, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0003483', 'decreased nerve fiber response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452400, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0002195', 'psychomotor seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452401, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0014253', 'decreased paired-pulse ratio', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452402, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452403, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0003465', 'increased single cell response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452404, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0005447', 'abnormal synaptic norepinephrine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452405, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452406, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0003990', 'decreased neurotransmitter release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452407, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0009435', 'abnormal miniature inhibitory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452408, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0004859', 'abnormal synaptic plasticity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452409, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0002826', 'tonic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452410, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0009244', 'abnormal acid-activated cation-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452411, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0001533', 'abnormal skeleton physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452412, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0011994', 'increased nerve conduction velocity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452413, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452414, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452415, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0012685', 'abnormal primitive streak elongation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452416, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0003475', 'increased summary potential intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452417, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0003444', 'abnormal neurotransmitter uptake', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452418, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0001663', 'abnormal digestive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452419, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0002911', 'abnormal inhibitory postsynaptic potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452420, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0021001', 'impaired neuron physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452421, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0003470', 'abnormal summary potential', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452422, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0001499', 'abnormal kindling response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452423, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0005666', 'abnormal adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452424, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0002106', 'abnormal muscle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452425, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0005403', 'abnormal nerve conduction', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452426, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452427, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0005621', 'abnormal cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452428, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452429, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0021009', 'abnormal synaptic physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452430, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0004513', 'avnosmia', 0.4838709677419355, 7.291997705654976, 1.878399847372025, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452431, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0002915', 'abnormal synaptic depression', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452432, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.46875, 7.291997705654976, 1.8488168985937385, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452433, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0003996', 'clonic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452434, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0004835', 'abnormal miniature endplate potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452435, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452436, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452437, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0003480', 'increased nerve fiber response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452438, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452439, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452440, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452441, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0002133', 'abnormal respiratory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452442, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0003880', 'abnormal central pattern generator function', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452443, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0002912', 'abnormal excitatory postsynaptic potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452444, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0003635', 'abnormal synaptic transmission', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452445, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452446, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0004836', 'abnormal synaptic acetylcholine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452447, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0001912', 'increased cerebrospinal fluid production', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452448, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0003484', 'abnormal channel response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452449, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0014256', 'decreased paired-pulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452450, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0002204', 'abnormal synaptic neurotransmitter level', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452451, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0000920', 'abnormal myelination', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452452, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0002064', 'seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452453, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0006058', 'decreased cerebral infarct size', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452454, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0003476', 'decreased summary potential intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452455, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0001985', 'abnormal gustatory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452456, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0005402', 'abnormal action potential', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452457, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452458, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0004811', 'abnormal neuron physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452459, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0002634', 'abnormal sensorimotor gating', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452460, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452461, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452462, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0014255', 'increased paired-pulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452463, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0002194', 'maximal tonic hindlimb extension seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452464, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0003220', 'decreased spike-wave discharge type II', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452465, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0010050', 'hypermyelination', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452466, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452467, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0003412', 'abnormal afterhyperpolarization', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452468, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0003889', 'enhanced sensorimotor gating', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452469, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0002919', 'enhanced paired-pulse facilitation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452470, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0009358', 'environmentally induced seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452471, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0003088', 'abnormal prepulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452472, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0003463', 'abnormal single cell response', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452473, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0003485', 'abnormal channel response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452474, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0000950', 'abnormal seizure response to pharmacological agent', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452475, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0031092', 'dysgeusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452476, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0002910', 'abnormal excitatory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452477, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0030990', 'nerve inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452478, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452479, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0002921', 'abnormal post-tetanic potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452480, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0003474', 'abnormal summary potential intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452481, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0001983', 'abnormal olfactory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452482, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0014254', 'increased paired-pulse ratio', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452483, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0001984', 'abnormal olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452484, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452485, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452486, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452487, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0006082', 'CNS inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452488, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0003467', 'abnormal single cell response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452489, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0002578', 'impaired ability to fire action potentials', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452490, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0000947', 'convulsive seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452491, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0003469', 'decreased single cell response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452492, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0001919', 'abnormal reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452493, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0004008', 'abnormal GABA-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452494, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0003482', 'increased nerve fiber response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452495, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0000921', 'demyelination', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452496, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452497, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0004770', 'abnormal synaptic vesicle recycling', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452498, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0004558', 'delayed allantois development', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452499, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0012011', 'febrile seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452500, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452501, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452502, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0003216', 'absence seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452503, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0002886', 'abnormal glutamate-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452504, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0004807', 'abnormal paired-pulse inhibition', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452505, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0008921', 'increased neurotransmitter release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452506, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(452507, 'HP:0030177', 'Abnormality of peripheral nervous system electrophysiology', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452508, 'HP:0034159', 'Paget disease of bone', 'MP:0003723', 'abnormal long bone morphology', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452509, 'HP:0034159', 'Paget disease of bone', 'MP:0000428', 'abnormal craniofacial morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(452510, 'HP:0034159', 'Paget disease of bone', 'MP:0002132', 'abnormal respiratory system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(452511, 'HP:0034159', 'Paget disease of bone', 'MP:0020982', 'abnormal skin adnexa development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(452512, 'HP:0034159', 'Paget disease of bone', 'MP:0002937', 'synovial hyperemia', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452513, 'HP:0034159', 'Paget disease of bone', 'MP:0010966', 'abnormal compact bone area', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452514, 'HP:0034159', 'Paget disease of bone', 'MP:0002160', 'abnormal reproductive system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(452515, 'HP:0034159', 'Paget disease of bone', 'MP:0010925', 'abnormal osteoid volume', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452516, 'HP:0034159', 'Paget disease of bone', 'MP:0006431', 'abnormal fibrocartilage morphology', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452517, 'HP:0034159', 'Paget disease of bone', 'MP:0009807', 'abnormal pelvic ligament morphology', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452518, 'HP:0034159', 'Paget disease of bone', 'MP:0013613', 'abnormal volumetric bone mineral density', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452519, 'HP:0034159', 'Paget disease of bone', 'MP:0013614', 'abnormal areal bone mineral density', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452520, 'HP:0034159', 'Paget disease of bone', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(452521, 'HP:0034159', 'Paget disease of bone', 'MP:0002111', 'abnormal tail morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(452522, 'HP:0034159', 'Paget disease of bone', 'MP:0004134', 'abnormal chest morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(452523, 'HP:0034159', 'Paget disease of bone', 'MP:0003279', 'aneurysm', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(452524, 'HP:0034159', 'Paget disease of bone', 'MP:0010874', 'abnormal bone volume', 0.5, 4.825104621810128, 1.5532392960857848, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452525, 'HP:0034159', 'Paget disease of bone', 'MP:0012070', 'abnormal susceptibility to osteoporosis', 0.5, 4.825104621810128, 1.5532392960857848, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452526, 'HP:0034159', 'Paget disease of bone', 'MP:0003632', 'abnormal nervous system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(452527, 'HP:0034159', 'Paget disease of bone', 'MP:0000162', 'lordosis', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452528, 'HP:0034159', 'Paget disease of bone', 'MP:0012071', 'increased susceptibility to osteoporosis', 0.48, 4.825104621810128, 1.5218574895399573, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452529, 'HP:0034159', 'Paget disease of bone', 'MP:0014134', 'abnormal embryo morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(452530, 'HP:0034159', 'Paget disease of bone', 'MP:0020009', 'abnormal bone mineral density of femur', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452531, 'HP:0034159', 'Paget disease of bone', 'MP:0008151', 'increased diameter of long bones', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452532, 'HP:0034159', 'Paget disease of bone', 'MP:0004214', 'abnormal long bone diaphysis morphology', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452533, 'HP:0034159', 'Paget disease of bone', 'MP:0010924', 'abnormal osteoid morphology', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452534, 'HP:0034159', 'Paget disease of bone', 'MP:0013630', 'increased bone trabecular spacing', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452535, 'HP:0034159', 'Paget disease of bone', 'MP:0013629', 'abnormal bone trabecular spacing', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452536, 'HP:0034159', 'Paget disease of bone', 'MP:0014024', 'increased subchondral bone mineral content', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452537, 'HP:0034159', 'Paget disease of bone', 'MP:0000130', 'abnormal trabecular bone morphology', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452538, 'HP:0034159', 'Paget disease of bone', 'MP:0030828', 'abnormal obturator foramen morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452539, 'HP:0034159', 'Paget disease of bone', 'MP:0031349', 'monostotic fibrous dysplasia', 0.48, 4.825104621810128, 1.5218574895399573, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452540, 'HP:0034159', 'Paget disease of bone', 'MP:0010678', 'abnormal skin adnexa morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(452541, 'HP:0034159', 'Paget disease of bone', 'MP:0030878', 'abnormal fibrous joint morphology', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452542, 'HP:0034159', 'Paget disease of bone', 'MP:0000131', 'abnormal long bone epiphysis morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452543, 'HP:0034159', 'Paget disease of bone', 'MP:0006429', 'abnormal hyaline cartilage morphology', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452544, 'HP:0034159', 'Paget disease of bone', 'MP:0006430', 'abnormal elastic cartilage morphology', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452545, 'HP:0034159', 'Paget disease of bone', 'MP:0005508', 'abnormal skeleton morphology', 0.5454545454545454, 4.825104621810128, 1.622305534805349, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452546, 'HP:0034159', 'Paget disease of bone', 'MP:0002108', 'abnormal muscle morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(452547, 'HP:0034159', 'Paget disease of bone', 'MP:0005504', 'abnormal ligament morphology', 0.5, 4.825104621810128, 1.5532392960857848, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452548, 'HP:0034159', 'Paget disease of bone', 'MP:0010931', 'abnormal trabecular bone connectivity density', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452549, 'HP:0034159', 'Paget disease of bone', 'MP:0000164', 'abnormal cartilage development', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452550, 'HP:0034159', 'Paget disease of bone', 'MP:0003385', 'abnormal body wall morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(452551, 'HP:0034159', 'Paget disease of bone', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(452552, 'HP:0034159', 'Paget disease of bone', 'MP:0030485', 'abnormal osteocyte lacunocanalicular system morphology', 0.5, 4.825104621810128, 1.5532392960857848, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452553, 'HP:0034159', 'Paget disease of bone', 'MP:0020973', 'abnormal gland development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(452554, 'HP:0034159', 'Paget disease of bone', 'MP:0000003', 'abnormal adipose tissue morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(452555, 'HP:0034159', 'Paget disease of bone', 'MP:0013631', 'decreased bone trabecular spacing', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452556, 'HP:0034159', 'Paget disease of bone', 'MP:0000685', 'abnormal immune system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(452557, 'HP:0034159', 'Paget disease of bone', 'MP:0013118', 'swellings', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(452558, 'HP:0034159', 'Paget disease of bone', 'MP:0008923', 'thoracoschisis', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(452559, 'HP:0034159', 'Paget disease of bone', 'MP:0000566', 'synostosis', 0.5, 4.825104621810128, 1.5532392960857848, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452560, 'HP:0034159', 'Paget disease of bone', 'MP:0000065', 'abnormal bone marrow cavity morphology', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452561, 'HP:0034159', 'Paget disease of bone', 'MP:0002925', 'abnormal cardiovascular development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(452562, 'HP:0034159', 'Paget disease of bone', 'MP:0006322', 'abnormal perichondrium morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452563, 'HP:0034159', 'Paget disease of bone', 'MP:0010933', 'decreased trabecular bone connectivity density', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452564, 'HP:0034159', 'Paget disease of bone', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(452565, 'HP:0034159', 'Paget disease of bone', 'MP:0005499', 'abnormal olfactory system morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(452566, 'HP:0034159', 'Paget disease of bone', 'MP:0004174', 'abnormal spine curvature', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452567, 'HP:0034159', 'Paget disease of bone', 'MP:0030866', 'abnormal synovial joint membrane morphology', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452568, 'HP:0034159', 'Paget disease of bone', 'MP:0003384', 'abnormal ventral body wall morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(452569, 'HP:0034159', 'Paget disease of bone', 'MP:0000997', 'abnormal synovial joint capsule morphology', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452570, 'HP:0034159', 'Paget disease of bone', 'MP:0004624', 'abnormal thoracic cage morphology', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452571, 'HP:0034159', 'Paget disease of bone', 'MP:0012426', 'decreased skeletal tumor incidence', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452572, 'HP:0034159', 'Paget disease of bone', 'MP:0000150', 'abnormal rib morphology', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452573, 'HP:0034159', 'Paget disease of bone', 'MP:0004703', 'abnormal vertebral column morphology', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452574, 'HP:0034159', 'Paget disease of bone', 'MP:0004508', 'abnormal pectoral girdle bone morphology', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452575, 'HP:0034159', 'Paget disease of bone', 'MP:0014136', 'abnormal extraembryonic endoderm morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(452576, 'HP:0034159', 'Paget disease of bone', 'MP:0010119', 'abnormal bone mineral density', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452577, 'HP:0034159', 'Paget disease of bone', 'MP:0002657', 'chondrodystrophy', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452578, 'HP:0034159', 'Paget disease of bone', 'MP:0013941', 'abnormal enthesis morphology', 0.48, 4.825104621810128, 1.5218574895399573, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452579, 'HP:0034159', 'Paget disease of bone', 'MP:0009877', 'exostosis', 0.5, 4.825104621810128, 1.5532392960857848, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452580, 'HP:0034159', 'Paget disease of bone', 'MP:0010970', 'abnormal compact bone lamellar structure', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452581, 'HP:0034159', 'Paget disease of bone', 'MP:0002825', 'abnormal notochord morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452582, 'HP:0034159', 'Paget disease of bone', 'MP:0011642', 'abnormal bone collagen fibril morphology', 0.48, 4.825104621810128, 1.5218574895399573, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452583, 'HP:0034159', 'Paget disease of bone', 'MP:0030484', 'abnormal osteocyte lacuna morphology', 0.48, 4.825104621810128, 1.5218574895399573, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452584, 'HP:0034159', 'Paget disease of bone', 'MP:0031312', 'spondylolysis', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452585, 'HP:0034159', 'Paget disease of bone', 'MP:0002114', 'abnormal axial skeleton morphology', 0.5, 4.825104621810128, 1.5532392960857848, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452586, 'HP:0034159', 'Paget disease of bone', 'MP:0014025', 'decreased subchondral bone mineral content', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452587, 'HP:0034159', 'Paget disease of bone', 'MP:0000160', 'kyphosis', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452588, 'HP:0034159', 'Paget disease of bone', 'MP:0009250', 'abnormal appendicular skeleton morphology', 0.5, 4.825104621810128, 1.5532392960857848, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452589, 'HP:0034159', 'Paget disease of bone', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(452590, 'HP:0034159', 'Paget disease of bone', 'MP:0010280', 'increased skeletal tumor incidence', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452591, 'HP:0034159', 'Paget disease of bone', 'MP:0008150', 'decreased diameter of long bones', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452592, 'HP:0034159', 'Paget disease of bone', 'MP:0010113', 'abnormal sacrum morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452593, 'HP:0034159', 'Paget disease of bone', 'MP:0006281', 'abnormal tail development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(452594, 'HP:0034159', 'Paget disease of bone', 'MP:0030818', 'abnormal girdle joint morphology', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452595, 'HP:0034159', 'Paget disease of bone', 'MP:0010233', 'hairless tail', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(452596, 'HP:0034159', 'Paget disease of bone', 'MP:0005500', 'abnormal gustatory system morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(452597, 'HP:0034159', 'Paget disease of bone', 'MP:0000161', 'scoliosis', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452598, 'HP:0034159', 'Paget disease of bone', 'MP:0003795', 'abnormal bone structure', 0.5217391304347826, 4.825104621810128, 1.5866461135489751, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452599, 'HP:0034159', 'Paget disease of bone', 'MP:0003797', 'abnormal compact bone morphology', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452600, 'HP:0034159', 'Paget disease of bone', 'MP:0030865', 'abnormal synovial joint cavity morphology', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452601, 'HP:0034159', 'Paget disease of bone', 'MP:0005605', 'increased bone mass', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452602, 'HP:0034159', 'Paget disease of bone', 'MP:0030875', 'abnormal cartilaginous joint morphology', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452603, 'HP:0034159', 'Paget disease of bone', 'MP:0005422', 'osteosclerosis', 0.5, 4.825104621810128, 1.5532392960857848, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452604, 'HP:0034159', 'Paget disease of bone', 'MP:0010124', 'decreased bone mineral content', 0.48, 4.825104621810128, 1.5218574895399573, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452605, 'HP:0034159', 'Paget disease of bone', 'MP:0005503', 'abnormal tendon morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452606, 'HP:0034159', 'Paget disease of bone', 'MP:0014137', 'abnormal preimplantation embryo morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(452607, 'HP:0034159', 'Paget disease of bone', 'MP:0013332', 'peliosis', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(452608, 'HP:0034159', 'Paget disease of bone', 'MP:0002109', 'abnormal limb morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(452609, 'HP:0034159', 'Paget disease of bone', 'MP:0013304', 'osteophytes', 0.5, 4.825104621810128, 1.5532392960857848, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452610, 'HP:0034159', 'Paget disease of bone', 'MP:0002163', 'abnormal gland morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(452611, 'HP:0034159', 'Paget disease of bone', 'MP:0000462', 'abnormal digestive system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(452612, 'HP:0034159', 'Paget disease of bone', 'MP:0031313', 'spondylolisthesis', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452613, 'HP:0034159', 'Paget disease of bone', 'MP:0014167', 'ectopic bone', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452614, 'HP:0034159', 'Paget disease of bone', 'MP:0004509', 'abnormal pelvic girdle bone morphology', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452615, 'HP:0034159', 'Paget disease of bone', 'MP:0010932', 'increased trabecular bone connectivity density', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452616, 'HP:0034159', 'Paget disease of bone', 'MP:0030486', 'abnormal osteocyte canaliculus morphology', 0.48, 4.825104621810128, 1.5218574895399573, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452617, 'HP:0034159', 'Paget disease of bone', 'MP:0030222', 'hyperostosis', 0.5217391304347826, 4.825104621810128, 1.5866461135489751, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452618, 'HP:0034159', 'Paget disease of bone', 'MP:0012072', 'decreased susceptibility to osteoporosis', 0.48, 4.825104621810128, 1.5218574895399573, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452619, 'HP:0034159', 'Paget disease of bone', 'MP:0010967', 'increased compact bone area', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452620, 'HP:0034159', 'Paget disease of bone', 'MP:0031310', 'abnormal cyst', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(452621, 'HP:0034159', 'Paget disease of bone', 'MP:0010971', 'abnormal periosteum morphology', 0.48, 4.825104621810128, 1.5218574895399573, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452622, 'HP:0034159', 'Paget disease of bone', 'MP:0030804', 'abnormal synovial joint morphology', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452623, 'HP:0034159', 'Paget disease of bone', 'MP:0002932', 'abnormal joint morphology', 0.5, 4.825104621810128, 1.5532392960857848, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452624, 'HP:0034159', 'Paget disease of bone', 'MP:0000133', 'abnormal long bone metaphysis morphology', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452625, 'HP:0034159', 'Paget disease of bone', 'MP:0002113', 'abnormal skeleton development', 0.5217391304347826, 4.825104621810128, 1.5866461135489751, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452626, 'HP:0034159', 'Paget disease of bone', 'MP:0031350', 'polyostotic fibrous dysplasia', 0.48, 4.825104621810128, 1.5218574895399573, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452627, 'HP:0034159', 'Paget disease of bone', 'MP:0013113', 'greasy tail', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(452628, 'HP:0034159', 'Paget disease of bone', 'MP:0000137', 'abnormal vertebrae morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452629, 'HP:0034159', 'Paget disease of bone', 'MP:0010867', 'abnormal bone trabecula morphology', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452630, 'HP:0034159', 'Paget disease of bone', 'MP:0010968', 'decreased compact bone area', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452631, 'HP:0034159', 'Paget disease of bone', 'MP:0000163', 'abnormal cartilage morphology', 0.48, 4.825104621810128, 1.5218574895399573, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452632, 'HP:0034159', 'Paget disease of bone', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(452633, 'HP:0034159', 'Paget disease of bone', 'MP:0010963', 'abnormal compact bone volume', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452634, 'HP:0034159', 'Paget disease of bone', 'MP:0009918', 'abnormal stylohyoid ligament morphology', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452635, 'HP:0034159', 'Paget disease of bone', 'MP:0010123', 'increased bone mineral content', 0.48, 4.825104621810128, 1.5218574895399573, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452636, 'HP:0034159', 'Paget disease of bone', 'MP:0010122', 'abnormal bone mineral content', 0.5, 4.825104621810128, 1.5532392960857848, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452637, 'HP:0034159', 'Paget disease of bone', 'MP:0031348', 'bone fibrous dysplasia', 0.5, 4.825104621810128, 1.5532392960857848, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452638, 'HP:0034159', 'Paget disease of bone', 'MP:0010877', 'abnormal trabecular bone volume', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452639, 'HP:0034159', 'Paget disease of bone', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(452640, 'HP:0034159', 'Paget disease of bone', 'MP:0000067', 'osteopetrosis', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(452641, 'HP:0000012', 'Urinary urgency', 'MP:0011432', 'decreased urine flow rate', 0.41935483870967744, 6.416088053379619, 1.6403102056538266, 'UPHENO:0002832', 'abnormal renal system'),
(452642, 'HP:0000012', 'Urinary urgency', 'MP:0001756', 'abnormal urination', 0.43333333333333335, 6.416088053379619, 1.6674246079301962, 'UPHENO:0002832', 'abnormal renal system'),
(452643, 'HP:0000012', 'Urinary urgency', 'MP:0003621', 'dysuria', 0.41935483870967744, 6.416088053379619, 1.6403102056538266, 'UPHENO:0002832', 'abnormal renal system'),
(452644, 'HP:0000012', 'Urinary urgency', 'MP:0003280', 'urinary incontinence', 0.41935483870967744, 6.416088053379619, 1.6403102056538266, 'UPHENO:0002832', 'abnormal renal system'),
(452645, 'HP:0000012', 'Urinary urgency', 'MP:0001985', 'abnormal gustatory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452646, 'HP:0000012', 'Urinary urgency', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.4482758620689655, 6.416088053379619, 1.6959296575150573, 'UPHENO:0002832', 'abnormal renal system'),
(452647, 'HP:0000012', 'Urinary urgency', 'MP:0001983', 'abnormal olfactory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452648, 'HP:0000012', 'Urinary urgency', 'MP:0002164', 'abnormal gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452649, 'HP:0000012', 'Urinary urgency', 'MP:0001761', 'abnormal urination pattern', 0.41935483870967744, 6.416088053379619, 1.6403102056538266, 'UPHENO:0002832', 'abnormal renal system'),
(452650, 'HP:0000012', 'Urinary urgency', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452651, 'HP:0000012', 'Urinary urgency', 'MP:0011431', 'increased urine flow rate', 0.41935483870967744, 6.416088053379619, 1.6403102056538266, 'UPHENO:0002832', 'abnormal renal system'),
(452652, 'HP:0000012', 'Urinary urgency', 'MP:0010386', 'abnormal urinary bladder physiology', 0.5333333333333333, 13.062826751687464, 2.6394773979394697, 'UPHENO:0002437', 'abnormality of urinary bladder physiology'),
(452653, 'HP:0000012', 'Urinary urgency', 'MP:0009646', 'urinary bladder inflammation', 0.42105263157894735, 13.062826751687464, 2.345237211809901, 'UPHENO:0002437', 'abnormality of urinary bladder physiology'),
(452654, 'HP:0000012', 'Urinary urgency', 'MP:0011923', 'abnormal bladder urine volume', 0.5161290322580645, 13.062826751687464, 2.596556205804759, 'UPHENO:0002437', 'abnormality of urinary bladder physiology'),
(452655, 'HP:0000012', 'Urinary urgency', 'MP:0014037', 'stranguria', 0.41935483870967744, 6.416088053379619, 1.6403102056538266, 'UPHENO:0002832', 'abnormal renal system'),
(452656, 'HP:0000012', 'Urinary urgency', 'MP:0010680', 'abnormal skin adnexa physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452657, 'HP:0000012', 'Urinary urgency', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452658, 'HP:0000012', 'Urinary urgency', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452659, 'HP:0000012', 'Urinary urgency', 'MP:0005302', 'neurogenic bladder', 0.42105263157894735, 13.062826751687464, 2.345237211809901, 'UPHENO:0002437', 'abnormality of urinary bladder physiology'),
(452660, 'HP:0000012', 'Urinary urgency', 'MP:0009643', 'abnormal urine homeostasis', 0.40625, 6.416088053379619, 1.6144769343925203, 'UPHENO:0002832', 'abnormal renal system'),
(452661, 'HP:0010308', 'Asternia', 'MP:0000158', 'absent sternum', 0.43333333333333335, 16.19210976863243, 2.6488829531975777, 'UPHENO:0025853', 'absent sternum in the independent continuant'),
(452662, 'HP:0032956', 'Renal tubular herpes simplex virus inclusions', 'MP:0011342', 'abnormal loop of Henle ascending limb morphology', 0.43902439024390244, 10.047451525800549, 2.1002562414190686, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(452663, 'HP:0032956', 'Renal tubular herpes simplex virus inclusions', 'MP:0000521', 'abnormal kidney cortex morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(452664, 'HP:0032956', 'Renal tubular herpes simplex virus inclusions', 'MP:0004967', 'abnormal kidney epithelium morphology', 0.45714285714285713, 8.472720947690348, 1.9680558584047614, 'UPHENO:0087993', 'abnormal kidney epithelium morphology'),
(452665, 'HP:0032956', 'Renal tubular herpes simplex virus inclusions', 'MP:0011534', 'granular kidney', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(452666, 'HP:0032956', 'Renal tubular herpes simplex virus inclusions', 'MP:0011350', 'abnormal proximal convoluted tubule brush border morphology', 0.42857142857142855, 10.047451525800549, 2.075102564673496, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(452667, 'HP:0032956', 'Renal tubular herpes simplex virus inclusions', 'MP:0011344', 'abnormal loop of Henle ascending limb thick segment morphology', 0.4186046511627907, 10.047451525800549, 2.050831524292717, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(452668, 'HP:0032956', 'Renal tubular herpes simplex virus inclusions', 'MP:0004755', 'abnormal loop of Henle morphology', 0.46153846153846156, 10.047451525800549, 2.1534357012922984, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(452669, 'HP:0032956', 'Renal tubular herpes simplex virus inclusions', 'MP:0011289', 'abnormal nephron number', 0.40476190476190477, 8.69825431939161, 1.876358704091628, 'UPHENO:0076756', 'abnormal nephron morphology'),
(452670, 'HP:0032956', 'Renal tubular herpes simplex virus inclusions', 'MP:0011843', 'abnormal kidney collecting duct epithelium morphology', 0.4146341463414634, 8.69825431939161, 1.8991032763864863, 'UPHENO:0076756', 'abnormal nephron morphology'),
(452671, 'HP:0032956', 'Renal tubular herpes simplex virus inclusions', 'MP:0002135', 'abnormal kidney morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(452672, 'HP:0032956', 'Renal tubular herpes simplex virus inclusions', 'MP:0012026', 'abnormal S-shaped body morphology', 0.4358974358974359, 8.69825431939161, 1.94718945010664, 'UPHENO:0076756', 'abnormal nephron morphology'),
(452673, 'HP:0032956', 'Renal tubular herpes simplex virus inclusions', 'MP:0004969', 'pale kidney', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(452674, 'HP:0032956', 'Renal tubular herpes simplex virus inclusions', 'MP:0011352', 'proximal convoluted tubule brush border loss', 0.4186046511627907, 10.047451525800549, 2.050831524292717, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(452675, 'HP:0032956', 'Renal tubular herpes simplex virus inclusions', 'MP:0011402', 'renal cast', 0.4594594594594595, 8.69825431939161, 1.9991236149444531, 'UPHENO:0076756', 'abnormal nephron morphology'),
(452676, 'HP:0032956', 'Renal tubular herpes simplex virus inclusions', 'MP:0012025', 'abnormal comma shaped body morphology', 0.4358974358974359, 8.69825431939161, 1.94718945010664, 'UPHENO:0076756', 'abnormal nephron morphology'),
(452677, 'HP:0032956', 'Renal tubular herpes simplex virus inclusions', 'MP:0004194', 'abnormal kidney pelvis morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(452678, 'HP:0032956', 'Renal tubular herpes simplex virus inclusions', 'MP:0011381', 'abnormal kidney lobe morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(452679, 'HP:0032956', 'Renal tubular herpes simplex virus inclusions', 'MP:0009640', 'abnormal renal tubule epithelium morphology', 0.46153846153846156, 10.047451525800549, 2.1534357012922984, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(452680, 'HP:0032956', 'Renal tubular herpes simplex virus inclusions', 'MP:0005325', 'abnormal renal glomerulus morphology', 0.40476190476190477, 8.69825431939161, 1.876358704091628, 'UPHENO:0076756', 'abnormal nephron morphology'),
(452681, 'HP:0032956', 'Renal tubular herpes simplex virus inclusions', 'MP:0003014', 'abnormal kidney medulla morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(452682, 'HP:0032956', 'Renal tubular herpes simplex virus inclusions', 'MP:0002827', 'abnormal renal corpuscle morphology', 0.425, 8.69825431939161, 1.9226955260106666, 'UPHENO:0076756', 'abnormal nephron morphology'),
(452683, 'HP:0032956', 'Renal tubular herpes simplex virus inclusions', 'MP:0011341', 'abnormal loop of Henle descending limb morphology', 0.43902439024390244, 10.047451525800549, 2.1002562414190686, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(452684, 'HP:0032956', 'Renal tubular herpes simplex virus inclusions', 'MP:0011351', 'absent proximal convoluted tubule brush border', 0.4186046511627907, 10.047451525800549, 2.050831524292717, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(452685, 'HP:0032956', 'Renal tubular herpes simplex virus inclusions', 'MP:0011331', 'abnormal papillary duct morphology', 0.4146341463414634, 8.69825431939161, 1.8991032763864863, 'UPHENO:0076756', 'abnormal nephron morphology'),
(452686, 'HP:0032956', 'Renal tubular herpes simplex virus inclusions', 'MP:0004754', 'abnormal kidney collecting duct morphology', 0.4358974358974359, 8.69825431939161, 1.94718945010664, 'UPHENO:0076756', 'abnormal nephron morphology'),
(452687, 'HP:0032956', 'Renal tubular herpes simplex virus inclusions', 'MP:0012024', 'abnormal nephron morphogenesis', 0.4594594594594595, 8.69825431939161, 1.9991236149444531, 'UPHENO:0076756', 'abnormal nephron morphology'),
(452688, 'HP:0032956', 'Renal tubular herpes simplex virus inclusions', 'MP:0011376', 'abnormal kidney corticomedullary boundary morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(452689, 'HP:0032956', 'Renal tubular herpes simplex virus inclusions', 'MP:0002828', 'abnormal renal glomerular capsule morphology', 0.40476190476190477, 8.69825431939161, 1.876358704091628, 'UPHENO:0076756', 'abnormal nephron morphology'),
(452690, 'HP:0032956', 'Renal tubular herpes simplex virus inclusions', 'MP:0011383', 'abnormal kidney capsule morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(452691, 'HP:0032956', 'Renal tubular herpes simplex virus inclusions', 'MP:0004757', 'abnormal distal convoluted tubule morphology', 0.43902439024390244, 10.047451525800549, 2.1002562414190686, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(452692, 'HP:0032956', 'Renal tubular herpes simplex virus inclusions', 'MP:0011425', 'abnormal kidney interstitium morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(452693, 'HP:0032956', 'Renal tubular herpes simplex virus inclusions', 'MP:0002703', 'abnormal renal tubule morphology', 0.4864864864864865, 10.047451525800549, 2.2108707313929497, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(452694, 'HP:0032956', 'Renal tubular herpes simplex virus inclusions', 'MP:0009860', 'nephrosclerosis', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(452695, 'HP:0032956', 'Renal tubular herpes simplex virus inclusions', 'MP:0000527', 'abnormal kidney development', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(452696, 'HP:0032956', 'Renal tubular herpes simplex virus inclusions', 'MP:0003881', 'abnormal nephron morphology', 0.4722222222222222, 8.69825431939161, 2.026699036403074, 'UPHENO:0076756', 'abnormal nephron morphology'),
(452697, 'HP:0032956', 'Renal tubular herpes simplex virus inclusions', 'MP:0004756', 'abnormal proximal convoluted tubule morphology', 0.43902439024390244, 10.047451525800549, 2.1002562414190686, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(452698, 'HP:0025066', 'Decreased mean corpuscular volume', 'MP:0009395', 'increased nucleated erythrocyte cell number', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(452699, 'HP:0025066', 'Decreased mean corpuscular volume', 'MP:0009547', 'elliptocytosis', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(452700, 'HP:0025066', 'Decreased mean corpuscular volume', 'MP:0011171', 'increased number of Heinz bodies', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(452701, 'HP:0025066', 'Decreased mean corpuscular volume', 'MP:0012379', 'abnormal erythrocyte sodium ion content', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(452702, 'HP:0025066', 'Decreased mean corpuscular volume', 'MP:0013707', 'abnormal hematopoietic precursor cell morphology', 0.42105263157894735, 7.94655706237675, 1.8291852730398854, 'UPHENO:0085118', 'abnormal hematopoietic cell morphology'),
(452703, 'HP:0025066', 'Decreased mean corpuscular volume', 'MP:0013702', 'abnormal megakaryocyte-erythroid progenitor cell morphology', 0.4146341463414634, 9.052558416233639, 1.9373951148697741, 'UPHENO:0085068', 'abnormal myeloid cell morphology'),
(452704, 'HP:0025066', 'Decreased mean corpuscular volume', 'MP:0002424', 'abnormal reticulocyte morphology', 0.43902439024390244, 10.15319077934013, 2.111278852006483, 'UPHENO:0088170', 'abnormal erythroid lineage cell morphology'),
(452705, 'HP:0025066', 'Decreased mean corpuscular volume', 'MP:0010067', 'increased red blood cell distribution width', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(452706, 'HP:0025066', 'Decreased mean corpuscular volume', 'MP:0010175', 'leptocytosis', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(452707, 'HP:0025066', 'Decreased mean corpuscular volume', 'MP:0009568', 'abnormal red blood cell deformability', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(452708, 'HP:0025066', 'Decreased mean corpuscular volume', 'MP:0012398', 'decreased nucleated erythrocyte cell number', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(452709, 'HP:0025066', 'Decreased mean corpuscular volume', 'MP:0010066', 'abnormal red blood cell distribution width', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(452710, 'HP:0025066', 'Decreased mean corpuscular volume', 'MP:0010074', 'stomatocytosis', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(452711, 'HP:0025066', 'Decreased mean corpuscular volume', 'MP:0000358', 'abnormal cell morphology', 0.4375, 6.121988824155609, 1.6365726719483247, 'UPHENO:0084928', 'abnormal cell morphology'),
(452712, 'HP:0025066', 'Decreased mean corpuscular volume', 'MP:0012373', 'abnormal erythrocyte magnesium ion content', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(452713, 'HP:0025066', 'Decreased mean corpuscular volume', 'MP:0010177', 'acanthocytosis', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(452714, 'HP:0025066', 'Decreased mean corpuscular volume', 'MP:0010178', 'increased number of Howell-Jolly bodies', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(452715, 'HP:0025066', 'Decreased mean corpuscular volume', 'MP:0010696', 'increased siderocyte number', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(452716, 'HP:0025066', 'Decreased mean corpuscular volume', 'MP:0005640', 'abnormal mean corpuscular hemoglobin concentration', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(452717, 'HP:0025066', 'Decreased mean corpuscular volume', 'MP:0002814', 'hyperchromasia', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(452718, 'HP:0025066', 'Decreased mean corpuscular volume', 'MP:0010068', 'decreased red blood cell distribution width', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(452719, 'HP:0025066', 'Decreased mean corpuscular volume', 'MP:0001588', 'abnormal hemoglobin', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(452720, 'HP:0025066', 'Decreased mean corpuscular volume', 'MP:0002447', 'abnormal erythrocyte morphology', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(452721, 'HP:0025066', 'Decreased mean corpuscular volume', 'MP:0005097', 'polychromatophilia', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(452722, 'HP:0025066', 'Decreased mean corpuscular volume', 'MP:0013658', 'abnormal myeloid cell morphology', 0.4594594594594595, 9.052558416233639, 2.0394321750545883, 'UPHENO:0085068', 'abnormal myeloid cell morphology'),
(452723, 'HP:0025066', 'Decreased mean corpuscular volume', 'MP:0012372', 'abnormal erythrocyte ion content', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(452724, 'HP:0025066', 'Decreased mean corpuscular volume', 'MP:0002608', 'increased hematocrit', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(452725, 'HP:0025066', 'Decreased mean corpuscular volume', 'MP:0012376', 'abnormal erythrocyte potassium ion content', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(452726, 'HP:0025066', 'Decreased mean corpuscular volume', 'MP:0012397', 'abnormal nucleated erythrocyte cell number', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(452727, 'HP:0025066', 'Decreased mean corpuscular volume', 'MP:0013659', 'abnormal erythroid lineage cell morphology', 0.46153846153846156, 10.15319077934013, 2.164737409480221, 'UPHENO:0088170', 'abnormal erythroid lineage cell morphology'),
(452728, 'HP:0025066', 'Decreased mean corpuscular volume', 'MP:0002596', 'abnormal hematocrit', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(452729, 'HP:0025066', 'Decreased mean corpuscular volume', 'MP:0010176', 'dacryocytosis', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(452730, 'HP:0025066', 'Decreased mean corpuscular volume', 'MP:0009840', 'abnormal foam cell morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(452731, 'HP:0025066', 'Decreased mean corpuscular volume', 'MP:0013656', 'abnormal hematopoietic cell morphology', 0.4444444444444444, 7.94655706237675, 1.8793092185252833, 'UPHENO:0085118', 'abnormal hematopoietic cell morphology'),
(452732, 'HP:0410317', 'Increased urinary 3-methylhistidine', 'MP:0020403', 'lysinuria', 0.47674418604651164, 11.226325483970346, 2.3134574569567197, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(452733, 'HP:0410317', 'Increased urinary 3-methylhistidine', 'MP:0011654', 'histidinuria', 0.5061728395061729, 11.226325483970346, 2.383791317930699, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(452734, 'HP:0410317', 'Increased urinary 3-methylhistidine', 'MP:0020401', 'argininuria', 0.4880952380952381, 11.226325483970346, 2.3408366047277083, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(452735, 'HP:0410317', 'Increased urinary 3-methylhistidine', 'MP:0030620', 'valinuria', 0.47674418604651164, 11.226325483970346, 2.3134574569567197, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(452736, 'HP:0410317', 'Increased urinary 3-methylhistidine', 'MP:0011765', 'oroticaciduria', 0.4605263157894737, 10.47786425096631, 2.1966638843573105, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(452737, 'HP:0410317', 'Increased urinary 3-methylhistidine', 'MP:0020404', 'prolinuria', 0.4880952380952381, 11.226325483970346, 2.3408366047277083, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(452738, 'HP:0410317', 'Increased urinary 3-methylhistidine', 'MP:0020405', 'taurinuria', 0.4880952380952381, 11.226325483970346, 2.3408366047277083, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(452739, 'HP:0410317', 'Increased urinary 3-methylhistidine', 'MP:0020406', 'hyperthreoninuria', 0.4880952380952381, 11.226325483970346, 2.3408366047277083, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(452740, 'HP:0410317', 'Increased urinary 3-methylhistidine', 'MP:0011470', 'increased urine creatinine level', 0.4177215189873418, 11.094077685671904, 2.1527273358747596, 'UPHENO:0051739', 'abnormal urine amino acid level'),
(452741, 'HP:0410317', 'Increased urinary 3-methylhistidine', 'MP:0030618', 'tryptophanuria', 0.5061728395061729, 11.226325483970346, 2.383791317930699, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(452742, 'HP:0410317', 'Increased urinary 3-methylhistidine', 'MP:0030613', 'dicarboxylic aciduria', 0.42105263157894735, 10.47786425096631, 2.1004124157403803, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(452743, 'HP:0410317', 'Increased urinary 3-methylhistidine', 'MP:0030689', 'cystathioninuria', 0.5, 11.226325483970346, 2.369211417747511, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(452744, 'HP:0410317', 'Increased urinary 3-methylhistidine', 'MP:0030682', 'hydroxyprolinuria', 0.49411764705882355, 11.226325483970346, 2.3552336472749227, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(452745, 'HP:0410317', 'Increased urinary 3-methylhistidine', 'MP:0030734', 'increased urine gamma-aminobutyric acid level', 0.5, 11.226325483970346, 2.369211417747511, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(452746, 'HP:0410317', 'Increased urinary 3-methylhistidine', 'MP:0013730', 'glutathionuria', 0.4883720930232558, 11.226325483970346, 2.3415003894014013, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(452747, 'HP:0410317', 'Increased urinary 3-methylhistidine', 'MP:0003311', 'aminoaciduria', 0.5263157894736842, 11.226325483970346, 2.4307596261219233, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(452748, 'HP:0410317', 'Increased urinary 3-methylhistidine', 'MP:0030616', 'hyperglycinuria', 0.47126436781609193, 11.226325483970346, 2.3001232971519086, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(452749, 'HP:0410317', 'Increased urinary 3-methylhistidine', 'MP:0030632', 'increased urine creatine level', 0.40476190476190477, 11.094077685671904, 2.119070554660487, 'UPHENO:0051739', 'abnormal urine amino acid level'),
(452750, 'HP:0410317', 'Increased urinary 3-methylhistidine', 'MP:0030617', 'hyperglutaminuria', 0.4880952380952381, 11.226325483970346, 2.3408366047277083, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(452751, 'HP:0410317', 'Increased urinary 3-methylhistidine', 'MP:0011516', 'aspartylglucosaminuria', 0.5194805194805194, 11.226325483970346, 2.4149238899539482, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(452752, 'HP:0410317', 'Increased urinary 3-methylhistidine', 'MP:0020402', 'ornithinuria', 0.5, 11.226325483970346, 2.369211417747511, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(452753, 'HP:0410317', 'Increased urinary 3-methylhistidine', 'MP:0020400', 'cystinuria', 0.525, 11.226325483970346, 2.427719275180809, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(452754, 'HP:0033088', 'Valinuria', 'MP:0020406', 'hyperthreoninuria', 0.5, 11.226325483970346, 2.369211417747511, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(452755, 'HP:0033088', 'Valinuria', 'MP:0020400', 'cystinuria', 0.5194805194805194, 11.226325483970346, 2.4149238899539482, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(452756, 'HP:0033088', 'Valinuria', 'MP:0011654', 'histidinuria', 0.5194805194805194, 11.226325483970346, 2.4149238899539482, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(452757, 'HP:0033088', 'Valinuria', 'MP:0020405', 'taurinuria', 0.5, 11.226325483970346, 2.369211417747511, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(452758, 'HP:0033088', 'Valinuria', 'MP:0030613', 'dicarboxylic aciduria', 0.4507042253521127, 10.47786425096631, 2.173112443150691, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(452759, 'HP:0033088', 'Valinuria', 'MP:0030689', 'cystathioninuria', 0.49382716049382713, 11.226325483970346, 2.354541236956483, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(452760, 'HP:0033088', 'Valinuria', 'MP:0003311', 'aminoaciduria', 0.5633802816901409, 11.226325483970346, 2.5148937181329196, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(452761, 'HP:0033088', 'Valinuria', 'MP:0011516', 'aspartylglucosaminuria', 0.5555555555555556, 11.226325483970346, 2.4973681128529366, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(452762, 'HP:0033088', 'Valinuria', 'MP:0020403', 'lysinuria', 0.4878048780487805, 11.226325483970346, 2.3401402380293517, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(452763, 'HP:0033088', 'Valinuria', 'MP:0030617', 'hyperglutaminuria', 0.5, 11.226325483970346, 2.369211417747511, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(452764, 'HP:0033088', 'Valinuria', 'MP:0030734', 'increased urine gamma-aminobutyric acid level', 0.49382716049382713, 11.226325483970346, 2.354541236956483, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(452765, 'HP:0033088', 'Valinuria', 'MP:0030616', 'hyperglycinuria', 0.5185185185185185, 12.982656403003482, 2.5945611892033544, 'UPHENO:0080641', 'increased level of proteinogenic amino acid in urine'),
(452766, 'HP:0033088', 'Valinuria', 'MP:0030682', 'hydroxyprolinuria', 0.4878048780487805, 11.226325483970346, 2.3401402380293517, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(452767, 'HP:0033088', 'Valinuria', 'MP:0011517', 'hyperoxaluria', 0.41025641025641024, 10.47786425096631, 2.0733091845538643, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(452768, 'HP:0033088', 'Valinuria', 'MP:0030620', 'valinuria', 0.4878048780487805, 11.226325483970346, 2.3401402380293517, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(452769, 'HP:0033088', 'Valinuria', 'MP:0020404', 'prolinuria', 0.5, 11.226325483970346, 2.369211417747511, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(452770, 'HP:0033088', 'Valinuria', 'MP:0011765', 'oroticaciduria', 0.4722222222222222, 10.47786425096631, 2.224383137126806, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(452771, 'HP:0033088', 'Valinuria', 'MP:0013730', 'glutathionuria', 0.4819277108433735, 11.226325483970346, 2.3260002884076467, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(452772, 'HP:0033088', 'Valinuria', 'MP:0030618', 'tryptophanuria', 0.5194805194805194, 11.226325483970346, 2.4149238899539482, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(452773, 'HP:0033088', 'Valinuria', 'MP:0011470', 'increased urine creatinine level', 0.4266666666666667, 11.094077685671904, 2.175654647660487, 'UPHENO:0051739', 'abnormal urine amino acid level'),
(452774, 'HP:0033088', 'Valinuria', 'MP:0020401', 'argininuria', 0.5, 11.226325483970346, 2.369211417747511, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(452775, 'HP:0033088', 'Valinuria', 'MP:0020402', 'ornithinuria', 0.49382716049382713, 11.226325483970346, 2.354541236956483, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(452776, 'HP:5000005', 'Anti-CASPR2', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452777, 'HP:5000005', 'Anti-CASPR2', 'MP:0031128', 'cardiovascular shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452778, 'HP:5000005', 'Anti-CASPR2', 'MP:0031091', 'hypogeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452779, 'HP:5000005', 'Anti-CASPR2', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452780, 'HP:5000005', 'Anti-CASPR2', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452781, 'HP:5000005', 'Anti-CASPR2', 'MP:0013561', 'abnormal endocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452782, 'HP:5000005', 'Anti-CASPR2', 'MP:0008687', 'increased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452783, 'HP:5000005', 'Anti-CASPR2', 'MP:0031469', 'abnormal pinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452784, 'HP:5000005', 'Anti-CASPR2', 'MP:0002419', 'abnormal innate immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452785, 'HP:5000005', 'Anti-CASPR2', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452786, 'HP:5000005', 'Anti-CASPR2', 'MP:0008814', 'decreased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452787, 'HP:5000005', 'Anti-CASPR2', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452788, 'HP:5000005', 'Anti-CASPR2', 'MP:0001756', 'abnormal urination', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452789, 'HP:5000005', 'Anti-CASPR2', 'MP:0005666', 'abnormal adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452790, 'HP:5000005', 'Anti-CASPR2', 'MP:0003566', 'abnormal cell adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452791, 'HP:5000005', 'Anti-CASPR2', 'MP:0008681', 'increased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452792, 'HP:5000005', 'Anti-CASPR2', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452793, 'HP:5000005', 'Anti-CASPR2', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452794, 'HP:5000005', 'Anti-CASPR2', 'MP:0003820', 'increased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452795, 'HP:5000005', 'Anti-CASPR2', 'MP:0010559', 'heart block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452796, 'HP:5000005', 'Anti-CASPR2', 'MP:0001943', 'abnormal respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452797, 'HP:5000005', 'Anti-CASPR2', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452798, 'HP:5000005', 'Anti-CASPR2', 'MP:0003394', 'increased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452799, 'HP:5000005', 'Anti-CASPR2', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452800, 'HP:5000005', 'Anti-CASPR2', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452801, 'HP:5000005', 'Anti-CASPR2', 'MP:0030951', 'abnormal endocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452802, 'HP:5000005', 'Anti-CASPR2', 'MP:0002626', 'increased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452803, 'HP:5000005', 'Anti-CASPR2', 'MP:0031009', 'abnormal sperm-egg fusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452804, 'HP:5000005', 'Anti-CASPR2', 'MP:0001950', 'abnormal respiratory sounds', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452805, 'HP:5000005', 'Anti-CASPR2', 'MP:0030215', 'facial muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452806, 'HP:5000005', 'Anti-CASPR2', 'MP:0013555', 'abnormal apocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452807, 'HP:5000005', 'Anti-CASPR2', 'MP:0011936', 'abnormal PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452808, 'HP:5000005', 'Anti-CASPR2', 'MP:0003898', 'abnormal QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452809, 'HP:5000005', 'Anti-CASPR2', 'MP:0003547', 'abnormal pulmonary pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452810, 'HP:5000005', 'Anti-CASPR2', 'MP:0011044', 'increased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452811, 'HP:5000005', 'Anti-CASPR2', 'MP:0001663', 'abnormal digestive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452812, 'HP:5000005', 'Anti-CASPR2', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452813, 'HP:5000005', 'Anti-CASPR2', 'MP:0004945', 'abnormal bone resorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452814, 'HP:5000005', 'Anti-CASPR2', 'MP:0003926', 'decreased cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452815, 'HP:5000005', 'Anti-CASPR2', 'MP:0031242', 'increased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452816, 'HP:5000005', 'Anti-CASPR2', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452817, 'HP:5000005', 'Anti-CASPR2', 'MP:0004780', 'abnormal surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452818, 'HP:5000005', 'Anti-CASPR2', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452819, 'HP:5000005', 'Anti-CASPR2', 'MP:0003123', 'paternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452820, 'HP:5000005', 'Anti-CASPR2', 'MP:0008861', 'abnormal hair shedding', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452821, 'HP:5000005', 'Anti-CASPR2', 'MP:0030909', 'abnormal melanocyte adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452822, 'HP:5000005', 'Anti-CASPR2', 'MP:0011432', 'decreased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452823, 'HP:5000005', 'Anti-CASPR2', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452824, 'HP:5000005', 'Anti-CASPR2', 'MP:0009732', 'ventricular premature beat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452825, 'HP:5000005', 'Anti-CASPR2', 'MP:0020946', 'increased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452826, 'HP:5000005', 'Anti-CASPR2', 'MP:0031110', 'meningitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452827, 'HP:5000005', 'Anti-CASPR2', 'MP:0001636', 'irregular heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452828, 'HP:5000005', 'Anti-CASPR2', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452829, 'HP:5000005', 'Anti-CASPR2', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452830, 'HP:5000005', 'Anti-CASPR2', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452831, 'HP:5000005', 'Anti-CASPR2', 'MP:0003463', 'abnormal single cell response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452832, 'HP:5000005', 'Anti-CASPR2', 'MP:0014275', 'increased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452833, 'HP:5000005', 'Anti-CASPR2', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452834, 'HP:5000005', 'Anti-CASPR2', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452835, 'HP:5000005', 'Anti-CASPR2', 'MP:0031306', 'abnormal cartilage physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452836, 'HP:5000005', 'Anti-CASPR2', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452837, 'HP:5000005', 'Anti-CASPR2', 'MP:0030129', 'tongue inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452838, 'HP:5000005', 'Anti-CASPR2', 'MP:0004031', 'insulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452839, 'HP:5000005', 'Anti-CASPR2', 'MP:0000501', 'abnormal digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452840, 'HP:5000005', 'Anti-CASPR2', 'MP:0020386', 'adipose tissue inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452841, 'HP:5000005', 'Anti-CASPR2', 'MP:0031014', 'polyspermy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452842, 'HP:5000005', 'Anti-CASPR2', 'MP:0004761', 'increased susceptibility to induced pancreatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452843, 'HP:5000005', 'Anti-CASPR2', 'MP:0002635', 'reduced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452844, 'HP:5000005', 'Anti-CASPR2', 'MP:0031302', 'syncope', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452845, 'HP:5000005', 'Anti-CASPR2', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452846, 'HP:5000005', 'Anti-CASPR2', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452847, 'HP:5000005', 'Anti-CASPR2', 'MP:0003471', 'abnormal summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452848, 'HP:5000005', 'Anti-CASPR2', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452849, 'HP:5000005', 'Anti-CASPR2', 'MP:0003474', 'abnormal summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452850, 'HP:5000005', 'Anti-CASPR2', 'MP:0008690', 'increased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452851, 'HP:5000005', 'Anti-CASPR2', 'MP:0031090', 'ageusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452852, 'HP:5000005', 'Anti-CASPR2', 'MP:0010504', 'abnormal RR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452853, 'HP:5000005', 'Anti-CASPR2', 'MP:0005621', 'abnormal cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452854, 'HP:5000005', 'Anti-CASPR2', 'MP:0031053', 'pleuritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452855, 'HP:5000005', 'Anti-CASPR2', 'MP:0011804', 'increased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452856, 'HP:5000005', 'Anti-CASPR2', 'MP:0001945', 'bronchoconstriction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452857, 'HP:5000005', 'Anti-CASPR2', 'MP:0002499', 'chronic inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452858, 'HP:5000005', 'Anti-CASPR2', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452859, 'HP:5000005', 'Anti-CASPR2', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452860, 'HP:5000005', 'Anti-CASPR2', 'MP:0008942', 'abnormal induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452861, 'HP:5000005', 'Anti-CASPR2', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452862, 'HP:5000005', 'Anti-CASPR2', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452863, 'HP:5000005', 'Anti-CASPR2', 'MP:0001819', 'abnormal immune cell physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452864, 'HP:5000005', 'Anti-CASPR2', 'MP:0008713', 'abnormal cytokine level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452865, 'HP:5000005', 'Anti-CASPR2', 'MP:0013644', 'increased vertebra maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452866, 'HP:5000005', 'Anti-CASPR2', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452867, 'HP:5000005', 'Anti-CASPR2', 'MP:0004947', 'skin inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452868, 'HP:5000005', 'Anti-CASPR2', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452869, 'HP:5000005', 'Anti-CASPR2', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452870, 'HP:5000005', 'Anti-CASPR2', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452871, 'HP:5000005', 'Anti-CASPR2', 'MP:0020002', 'increased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452872, 'HP:5000005', 'Anti-CASPR2', 'MP:0020925', 'increased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452873, 'HP:5000005', 'Anti-CASPR2', 'MP:0010752', 'impaired mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452874, 'HP:5000005', 'Anti-CASPR2', 'MP:0006002', 'abnormal small intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452875, 'HP:5000005', 'Anti-CASPR2', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452876, 'HP:5000005', 'Anti-CASPR2', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452877, 'HP:5000005', 'Anti-CASPR2', 'MP:0030987', 'spinal cord inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452878, 'HP:5000005', 'Anti-CASPR2', 'MP:0008684', 'increased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452879, 'HP:5000005', 'Anti-CASPR2', 'MP:0009247', 'meteorism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452880, 'HP:5000005', 'Anti-CASPR2', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452881, 'HP:5000005', 'Anti-CASPR2', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452882, 'HP:5000005', 'Anti-CASPR2', 'MP:0000423', 'delayed hair regrowth', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452883, 'HP:5000005', 'Anti-CASPR2', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452884, 'HP:5000005', 'Anti-CASPR2', 'MP:0006114', 'cardiac murmur', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452885, 'HP:5000005', 'Anti-CASPR2', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452886, 'HP:5000005', 'Anti-CASPR2', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452887, 'HP:5000005', 'Anti-CASPR2', 'MP:0031224', 'abnormal CXCL10 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452888, 'HP:5000005', 'Anti-CASPR2', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452889, 'HP:5000005', 'Anti-CASPR2', 'MP:0008737', 'abnormal spleen physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452890, 'HP:5000005', 'Anti-CASPR2', 'MP:0002471', 'abnormal complement pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452891, 'HP:5000005', 'Anti-CASPR2', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452892, 'HP:5000005', 'Anti-CASPR2', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452893, 'HP:5000005', 'Anti-CASPR2', 'MP:0031130', 'right-to-left shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452894, 'HP:5000005', 'Anti-CASPR2', 'MP:0005000', 'abnormal immune tolerance', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452895, 'HP:5000005', 'Anti-CASPR2', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452896, 'HP:5000005', 'Anti-CASPR2', 'MP:0010950', 'abnormal lung hysteresivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452897, 'HP:5000005', 'Anti-CASPR2', 'MP:0001963', 'abnormal hearing physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452898, 'HP:5000005', 'Anti-CASPR2', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452899, 'HP:5000005', 'Anti-CASPR2', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452900, 'HP:5000005', 'Anti-CASPR2', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452901, 'HP:5000005', 'Anti-CASPR2', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452902, 'HP:5000005', 'Anti-CASPR2', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452903, 'HP:5000005', 'Anti-CASPR2', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452904, 'HP:5000005', 'Anti-CASPR2', 'MP:0020953', 'decreased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452905, 'HP:5000005', 'Anti-CASPR2', 'MP:0008565', 'decreased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452906, 'HP:5000005', 'Anti-CASPR2', 'MP:0002106', 'abnormal muscle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452907, 'HP:5000005', 'Anti-CASPR2', 'MP:0005403', 'abnormal nerve conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452908, 'HP:5000005', 'Anti-CASPR2', 'MP:0010381', 'abnormal dosage compensation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452909, 'HP:5000005', 'Anti-CASPR2', 'MP:0031170', 'abnormal vasculature physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452910, 'HP:5000005', 'Anti-CASPR2', 'MP:0020940', 'increased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452911, 'HP:5000005', 'Anti-CASPR2', 'MP:0000503', 'excessive digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452912, 'HP:5000005', 'Anti-CASPR2', 'MP:0003875', 'abnormal hair follicle regression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452913, 'HP:5000005', 'Anti-CASPR2', 'MP:0003186', 'abnormal redox activity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452914, 'HP:5000005', 'Anti-CASPR2', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452915, 'HP:5000005', 'Anti-CASPR2', 'MP:0020001', 'decreased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452916, 'HP:5000005', 'Anti-CASPR2', 'MP:0001933', 'abnormal litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452917, 'HP:5000005', 'Anti-CASPR2', 'MP:0001853', 'heart inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452918, 'HP:5000005', 'Anti-CASPR2', 'MP:0004760', 'increased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452919, 'HP:5000005', 'Anti-CASPR2', 'MP:0003889', 'enhanced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452920, 'HP:5000005', 'Anti-CASPR2', 'MP:0008750', 'abnormal interferon level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452921, 'HP:5000005', 'Anti-CASPR2', 'MP:0005333', 'decreased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452922, 'HP:5000005', 'Anti-CASPR2', 'MP:0030153', 'dental pulp inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452923, 'HP:5000005', 'Anti-CASPR2', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452924, 'HP:5000005', 'Anti-CASPR2', 'MP:0002998', 'abnormal bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452925, 'HP:5000005', 'Anti-CASPR2', 'MP:0009697', 'abnormal copulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452926, 'HP:5000005', 'Anti-CASPR2', 'MP:0013459', 'perioral dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452927, 'HP:5000005', 'Anti-CASPR2', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452928, 'HP:5000005', 'Anti-CASPR2', 'MP:0005402', 'abnormal action potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452929, 'HP:5000005', 'Anti-CASPR2', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452930, 'HP:5000005', 'Anti-CASPR2', 'MP:0008721', 'abnormal chemokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452931, 'HP:5000005', 'Anti-CASPR2', 'MP:0020947', 'decreased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452932, 'HP:5000005', 'Anti-CASPR2', 'MP:0002420', 'abnormal adaptive immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452933, 'HP:5000005', 'Anti-CASPR2', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452934, 'HP:5000005', 'Anti-CASPR2', 'MP:0005087', 'decreased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452935, 'HP:5000005', 'Anti-CASPR2', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452936, 'HP:5000005', 'Anti-CASPR2', 'MP:0004213', 'abnormal umami taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452937, 'HP:5000005', 'Anti-CASPR2', 'MP:0005501', 'abnormal skin physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452938, 'HP:5000005', 'Anti-CASPR2', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452939, 'HP:5000005', 'Anti-CASPR2', 'MP:0002405', 'respiratory system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452940, 'HP:5000005', 'Anti-CASPR2', 'MP:0030924', 'early exit from telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452941, 'HP:5000005', 'Anti-CASPR2', 'MP:0020952', 'increased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452942, 'HP:5000005', 'Anti-CASPR2', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452943, 'HP:5000005', 'Anti-CASPR2', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452944, 'HP:5000005', 'Anti-CASPR2', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452945, 'HP:5000005', 'Anti-CASPR2', 'MP:0020381', 'muscle gating pore current', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452946, 'HP:5000005', 'Anti-CASPR2', 'MP:0031222', 'decreased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452947, 'HP:5000005', 'Anti-CASPR2', 'MP:0010538', 'increased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452948, 'HP:5000005', 'Anti-CASPR2', 'MP:0008005', 'decreased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452949, 'HP:5000005', 'Anti-CASPR2', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452950, 'HP:5000005', 'Anti-CASPR2', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452951, 'HP:5000005', 'Anti-CASPR2', 'MP:0002338', 'abnormal pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452952, 'HP:5000005', 'Anti-CASPR2', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452953, 'HP:5000005', 'Anti-CASPR2', 'MP:0003260', 'vomiting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452954, 'HP:5000005', 'Anti-CASPR2', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452955, 'HP:5000005', 'Anti-CASPR2', 'MP:0008558', 'abnormal interferon-beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452956, 'HP:5000005', 'Anti-CASPR2', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452957, 'HP:5000005', 'Anti-CASPR2', 'MP:0001850', 'increased susceptibility to otitis media', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452958, 'HP:5000005', 'Anti-CASPR2', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452959, 'HP:5000005', 'Anti-CASPR2', 'MP:0008672', 'increased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452960, 'HP:5000005', 'Anti-CASPR2', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452961, 'HP:5000005', 'Anti-CASPR2', 'MP:0002472', 'impaired complement alternative pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452962, 'HP:5000005', 'Anti-CASPR2', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452963, 'HP:5000005', 'Anti-CASPR2', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452964, 'HP:5000005', 'Anti-CASPR2', 'MP:0003259', 'nausea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452965, 'HP:5000005', 'Anti-CASPR2', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452966, 'HP:5000005', 'Anti-CASPR2', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452967, 'HP:5000005', 'Anti-CASPR2', 'MP:0011013', 'bronchiolectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452968, 'HP:5000005', 'Anti-CASPR2', 'MP:0008705', 'increased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452969, 'HP:5000005', 'Anti-CASPR2', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452970, 'HP:5000005', 'Anti-CASPR2', 'MP:0002500', 'granulomatous inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452971, 'HP:5000005', 'Anti-CASPR2', 'MP:0010143', 'enhanced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452972, 'HP:5000005', 'Anti-CASPR2', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452973, 'HP:5000005', 'Anti-CASPR2', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452974, 'HP:5000005', 'Anti-CASPR2', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452975, 'HP:5000005', 'Anti-CASPR2', 'MP:0031126', 'gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452976, 'HP:5000005', 'Anti-CASPR2', 'MP:0003824', 'decreased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452977, 'HP:5000005', 'Anti-CASPR2', 'MP:0008706', 'decreased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452978, 'HP:5000005', 'Anti-CASPR2', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452979, 'HP:5000005', 'Anti-CASPR2', 'MP:0001876', 'decreased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452980, 'HP:5000005', 'Anti-CASPR2', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452981, 'HP:5000005', 'Anti-CASPR2', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452982, 'HP:5000005', 'Anti-CASPR2', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452983, 'HP:5000005', 'Anti-CASPR2', 'MP:0008652', 'decreased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452984, 'HP:5000005', 'Anti-CASPR2', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452985, 'HP:5000005', 'Anti-CASPR2', 'MP:0008272', 'abnormal endochondral bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452986, 'HP:5000005', 'Anti-CASPR2', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452987, 'HP:5000005', 'Anti-CASPR2', 'MP:0010753', 'improved mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452988, 'HP:5000005', 'Anti-CASPR2', 'MP:0010155', 'abnormal intestine physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452989, 'HP:5000005', 'Anti-CASPR2', 'MP:0003699', 'abnormal female reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452990, 'HP:5000005', 'Anti-CASPR2', 'MP:0001919', 'abnormal reproductive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452991, 'HP:5000005', 'Anti-CASPR2', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452992, 'HP:5000005', 'Anti-CASPR2', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452993, 'HP:5000005', 'Anti-CASPR2', 'MP:0030130', 'gum inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452994, 'HP:5000005', 'Anti-CASPR2', 'MP:0008001', 'hypochlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452995, 'HP:5000005', 'Anti-CASPR2', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452996, 'HP:5000005', 'Anti-CASPR2', 'MP:0020096', 'high mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452997, 'HP:5000005', 'Anti-CASPR2', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(452998, 'HP:5000005', 'Anti-CASPR2', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(452999, 'HP:5000005', 'Anti-CASPR2', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453000, 'HP:5000005', 'Anti-CASPR2', 'MP:0001947', 'abnormal mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453001, 'HP:5000005', 'Anti-CASPR2', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453002, 'HP:5000005', 'Anti-CASPR2', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453003, 'HP:5000005', 'Anti-CASPR2', 'MP:0004085', 'abnormal heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453004, 'HP:5000005', 'Anti-CASPR2', 'MP:0003899', 'abnormal QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453005, 'HP:5000005', 'Anti-CASPR2', 'MP:0010072', 'increased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453006, 'HP:5000005', 'Anti-CASPR2', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453007, 'HP:5000005', 'Anti-CASPR2', 'MP:0003897', 'abnormal ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453008, 'HP:5000005', 'Anti-CASPR2', 'MP:0020846', 'abnormal cell motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453009, 'HP:5000005', 'Anti-CASPR2', 'MP:0002133', 'abnormal respiratory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453010, 'HP:5000005', 'Anti-CASPR2', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453011, 'HP:5000005', 'Anti-CASPR2', 'MP:0003292', 'melena', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453012, 'HP:5000005', 'Anti-CASPR2', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453013, 'HP:5000005', 'Anti-CASPR2', 'MP:0008555', 'abnormal interferon secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453014, 'HP:5000005', 'Anti-CASPR2', 'MP:0011762', 'renal/urinary system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453015, 'HP:5000005', 'Anti-CASPR2', 'MP:0003787', 'abnormal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453016, 'HP:5000005', 'Anti-CASPR2', 'MP:0003261', 'hematemesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453017, 'HP:5000005', 'Anti-CASPR2', 'MP:0009567', 'mitotic nondisjunction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453018, 'HP:5000005', 'Anti-CASPR2', 'MP:0011994', 'increased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453019, 'HP:5000005', 'Anti-CASPR2', 'MP:0002498', 'abnormal acute inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453020, 'HP:5000005', 'Anti-CASPR2', 'MP:0004145', 'abnormal muscle electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453021, 'HP:5000005', 'Anti-CASPR2', 'MP:0031055', 'bronchitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453022, 'HP:5000005', 'Anti-CASPR2', 'MP:0020937', 'increased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453023, 'HP:5000005', 'Anti-CASPR2', 'MP:0003621', 'dysuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453024, 'HP:5000005', 'Anti-CASPR2', 'MP:0008708', 'increased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453025, 'HP:5000005', 'Anti-CASPR2', 'MP:0008696', 'increased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453026, 'HP:5000005', 'Anti-CASPR2', 'MP:0031223', 'increased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453027, 'HP:5000005', 'Anti-CASPR2', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453028, 'HP:5000005', 'Anti-CASPR2', 'MP:0008817', 'hematoma', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453029, 'HP:5000005', 'Anti-CASPR2', 'MP:0020155', 'enhanced humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453030, 'HP:5000005', 'Anti-CASPR2', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453031, 'HP:5000005', 'Anti-CASPR2', 'MP:0020926', 'decreased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453032, 'HP:5000005', 'Anti-CASPR2', 'MP:0009384', 'cardiac valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453033, 'HP:5000005', 'Anti-CASPR2', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453034, 'HP:5000005', 'Anti-CASPR2', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453035, 'HP:5000005', 'Anti-CASPR2', 'MP:0001533', 'abnormal skeleton physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453036, 'HP:5000005', 'Anti-CASPR2', 'MP:0003454', 'erythroderma', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453037, 'HP:5000005', 'Anti-CASPR2', 'MP:0031086', 'wheezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453038, 'HP:5000005', 'Anti-CASPR2', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453039, 'HP:5000005', 'Anti-CASPR2', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453040, 'HP:5000005', 'Anti-CASPR2', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453041, 'HP:5000005', 'Anti-CASPR2', 'MP:0012197', 'impaired myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453042, 'HP:5000005', 'Anti-CASPR2', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453043, 'HP:5000005', 'Anti-CASPR2', 'MP:0004143', 'muscle hypertonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453044, 'HP:5000005', 'Anti-CASPR2', 'MP:0004759', 'decreased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453045, 'HP:5000005', 'Anti-CASPR2', 'MP:0020412', 'abnormal amnion physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453046, 'HP:5000005', 'Anti-CASPR2', 'MP:0001985', 'abnormal gustatory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453047, 'HP:5000005', 'Anti-CASPR2', 'MP:0011763', 'urethritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453048, 'HP:5000005', 'Anti-CASPR2', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453049, 'HP:5000005', 'Anti-CASPR2', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453050, 'HP:5000005', 'Anti-CASPR2', 'MP:0031105', 'rhonchi', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453051, 'HP:5000005', 'Anti-CASPR2', 'MP:0000738', 'impaired muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453052, 'HP:5000005', 'Anti-CASPR2', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453053, 'HP:5000005', 'Anti-CASPR2', 'MP:0003122', 'maternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453054, 'HP:5000005', 'Anti-CASPR2', 'MP:0004142', 'abnormal muscle tone', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453055, 'HP:5000005', 'Anti-CASPR2', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453056, 'HP:5000005', 'Anti-CASPR2', 'MP:0011951', 'increased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453057, 'HP:5000005', 'Anti-CASPR2', 'MP:0010954', 'abnormal cellular respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453058, 'HP:5000005', 'Anti-CASPR2', 'MP:0001844', 'autoimmune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453059, 'HP:5000005', 'Anti-CASPR2', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453060, 'HP:5000005', 'Anti-CASPR2', 'MP:0012120', 'trophectoderm cell degeneration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453061, 'HP:5000005', 'Anti-CASPR2', 'MP:0000751', 'myopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453062, 'HP:5000005', 'Anti-CASPR2', 'MP:0031425', 'enhanced male fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453063, 'HP:5000005', 'Anti-CASPR2', 'MP:0013556', 'abnormal holocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453064, 'HP:5000005', 'Anti-CASPR2', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453065, 'HP:5000005', 'Anti-CASPR2', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453066, 'HP:5000005', 'Anti-CASPR2', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453067, 'HP:5000005', 'Anti-CASPR2', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453068, 'HP:5000005', 'Anti-CASPR2', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453069, 'HP:5000005', 'Anti-CASPR2', 'MP:0008693', 'increased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453070, 'HP:5000005', 'Anti-CASPR2', 'MP:0031221', 'abnormal CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453071, 'HP:5000005', 'Anti-CASPR2', 'MP:0003880', 'abnormal central pattern generator function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453072, 'HP:5000005', 'Anti-CASPR2', 'MP:0031066', 'cytokine storm', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453073, 'HP:5000005', 'Anti-CASPR2', 'MP:0003866', 'abnormal defecation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453074, 'HP:5000005', 'Anti-CASPR2', 'MP:0003464', 'abnormal single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453075, 'HP:5000005', 'Anti-CASPR2', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453076, 'HP:5000005', 'Anti-CASPR2', 'MP:0031169', 'abnormal joint physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453077, 'HP:5000005', 'Anti-CASPR2', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453078, 'HP:5000005', 'Anti-CASPR2', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453079, 'HP:5000005', 'Anti-CASPR2', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453080, 'HP:5000005', 'Anti-CASPR2', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453081, 'HP:5000005', 'Anti-CASPR2', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453082, 'HP:5000005', 'Anti-CASPR2', 'MP:0020142', 'increased anti-sperm antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453083, 'HP:5000005', 'Anti-CASPR2', 'MP:0003467', 'abnormal single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453084, 'HP:5000005', 'Anti-CASPR2', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453085, 'HP:5000005', 'Anti-CASPR2', 'MP:0010695', 'abnormal blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453086, 'HP:5000005', 'Anti-CASPR2', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453087, 'HP:5000005', 'Anti-CASPR2', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453088, 'HP:5000005', 'Anti-CASPR2', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453089, 'HP:5000005', 'Anti-CASPR2', 'MP:0011046', 'abnormal lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453090, 'HP:5000005', 'Anti-CASPR2', 'MP:0013498', 'trachea inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453091, 'HP:5000005', 'Anti-CASPR2', 'MP:0001841', 'decreased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453092, 'HP:5000005', 'Anti-CASPR2', 'MP:0012685', 'abnormal primitive streak elongation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453093, 'HP:5000005', 'Anti-CASPR2', 'MP:0004212', 'abnormal salty taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453094, 'HP:5000005', 'Anti-CASPR2', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453095, 'HP:5000005', 'Anti-CASPR2', 'MP:0003659', 'abnormal lymph circulation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453096, 'HP:5000005', 'Anti-CASPR2', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453097, 'HP:5000005', 'Anti-CASPR2', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453098, 'HP:5000005', 'Anti-CASPR2', 'MP:0008006', 'increased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453099, 'HP:5000005', 'Anti-CASPR2', 'MP:0006001', 'abnormal intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453100, 'HP:5000005', 'Anti-CASPR2', 'MP:0003633', 'abnormal nervous system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453101, 'HP:5000005', 'Anti-CASPR2', 'MP:0002254', 'reproductive system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453102, 'HP:5000005', 'Anti-CASPR2', 'MP:0005645', 'abnormal hypothalamus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453103, 'HP:5000005', 'Anti-CASPR2', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453104, 'HP:5000005', 'Anti-CASPR2', 'MP:0031054', 'bronchiolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453105, 'HP:5000005', 'Anti-CASPR2', 'MP:0000304', 'abnormal cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453106, 'HP:5000005', 'Anti-CASPR2', 'MP:0009643', 'abnormal urine homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453107, 'HP:5000005', 'Anti-CASPR2', 'MP:0031092', 'dysgeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453108, 'HP:5000005', 'Anti-CASPR2', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453109, 'HP:5000005', 'Anti-CASPR2', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453110, 'HP:5000005', 'Anti-CASPR2', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453111, 'HP:5000005', 'Anti-CASPR2', 'MP:0020848', 'abnormal exocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453112, 'HP:5000005', 'Anti-CASPR2', 'MP:0001194', 'dermatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453113, 'HP:5000005', 'Anti-CASPR2', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453114, 'HP:5000005', 'Anti-CASPR2', 'MP:0005001', 'abnormal clonal deletion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453115, 'HP:5000005', 'Anti-CASPR2', 'MP:0001835', 'abnormal antigen presentation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453116, 'HP:5000005', 'Anti-CASPR2', 'MP:0013641', 'increased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453117, 'HP:5000005', 'Anti-CASPR2', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453118, 'HP:5000005', 'Anti-CASPR2', 'MP:0011047', 'increased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453119, 'HP:5000005', 'Anti-CASPR2', 'MP:0011012', 'bronchiectasis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453120, 'HP:5000005', 'Anti-CASPR2', 'MP:0011399', 'increased endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453121, 'HP:5000005', 'Anti-CASPR2', 'MP:0011926', 'abnormal heart valve physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453122, 'HP:5000005', 'Anti-CASPR2', 'MP:0008002', 'hyperchlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453123, 'HP:5000005', 'Anti-CASPR2', 'MP:0002406', 'increased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453124, 'HP:5000005', 'Anti-CASPR2', 'MP:0013971', 'blood in lymph vessels', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453125, 'HP:5000005', 'Anti-CASPR2', 'MP:0004558', 'delayed allantois development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453126, 'HP:5000005', 'Anti-CASPR2', 'MP:0005190', 'osteomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453127, 'HP:5000005', 'Anti-CASPR2', 'MP:0000505', 'decreased digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453128, 'HP:5000005', 'Anti-CASPR2', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453129, 'HP:5000005', 'Anti-CASPR2', 'MP:0008752', 'abnormal tumor necrosis factor level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453130, 'HP:5000005', 'Anti-CASPR2', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453131, 'HP:5000005', 'Anti-CASPR2', 'MP:0001846', 'increased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453132, 'HP:5000005', 'Anti-CASPR2', 'MP:0031095', 'pharyngitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453133, 'HP:5000005', 'Anti-CASPR2', 'MP:0003470', 'abnormal summary potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453134, 'HP:5000005', 'Anti-CASPR2', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453135, 'HP:5000005', 'Anti-CASPR2', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453136, 'HP:5000005', 'Anti-CASPR2', 'MP:0001861', 'lung inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453137, 'HP:5000005', 'Anti-CASPR2', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453138, 'HP:5000005', 'Anti-CASPR2', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453139, 'HP:5000005', 'Anti-CASPR2', 'MP:0001872', 'sinus inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453140, 'HP:5000005', 'Anti-CASPR2', 'MP:0008568', 'abnormal interleukin secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453141, 'HP:5000005', 'Anti-CASPR2', 'MP:0010377', 'abnormal gut flora balance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453142, 'HP:5000005', 'Anti-CASPR2', 'MP:0005044', 'sepsis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453143, 'HP:5000005', 'Anti-CASPR2', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453144, 'HP:5000005', 'Anti-CASPR2', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453145, 'HP:5000005', 'Anti-CASPR2', 'MP:0020138', 'delayed bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453146, 'HP:5000005', 'Anti-CASPR2', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453147, 'HP:5000005', 'Anti-CASPR2', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453148, 'HP:5000005', 'Anti-CASPR2', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453149, 'HP:5000005', 'Anti-CASPR2', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453150, 'HP:5000005', 'Anti-CASPR2', 'MP:0004751', 'increased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453151, 'HP:5000005', 'Anti-CASPR2', 'MP:0003077', 'abnormal cell cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453152, 'HP:5000005', 'Anti-CASPR2', 'MP:0002933', 'joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453153, 'HP:5000005', 'Anti-CASPR2', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453154, 'HP:5000005', 'Anti-CASPR2', 'MP:0031246', 'abnormal CCL3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453155, 'HP:5000005', 'Anti-CASPR2', 'MP:0002128', 'abnormal blood circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453156, 'HP:5000005', 'Anti-CASPR2', 'MP:0003698', 'abnormal male reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453157, 'HP:5000005', 'Anti-CASPR2', 'MP:0030214', 'muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453158, 'HP:5000005', 'Anti-CASPR2', 'MP:0002409', 'decreased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453159, 'HP:5000005', 'Anti-CASPR2', 'MP:0008748', 'abnormal central T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453160, 'HP:5000005', 'Anti-CASPR2', 'MP:0001627', 'abnormal cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453161, 'HP:5000005', 'Anti-CASPR2', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453162, 'HP:5000005', 'Anti-CASPR2', 'MP:0001629', 'abnormal heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453163, 'HP:5000005', 'Anti-CASPR2', 'MP:0013134', 'poor circulation in autopods', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453164, 'HP:5000005', 'Anti-CASPR2', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453165, 'HP:5000005', 'Anti-CASPR2', 'MP:0001983', 'abnormal olfactory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453166, 'HP:5000005', 'Anti-CASPR2', 'MP:0005025', 'abnormal response to infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453167, 'HP:5000005', 'Anti-CASPR2', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453168, 'HP:5000005', 'Anti-CASPR2', 'MP:0031088', 'coughing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453169, 'HP:5000005', 'Anti-CASPR2', 'MP:0005410', 'abnormal fertilization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453170, 'HP:5000005', 'Anti-CASPR2', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453171, 'HP:5000005', 'Anti-CASPR2', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453172, 'HP:5000005', 'Anti-CASPR2', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453173, 'HP:5000005', 'Anti-CASPR2', 'MP:0008711', 'increased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453174, 'HP:5000005', 'Anti-CASPR2', 'MP:0008666', 'increased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453175, 'HP:5000005', 'Anti-CASPR2', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453176, 'HP:5000005', 'Anti-CASPR2', 'MP:0001914', 'hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453177, 'HP:5000005', 'Anti-CASPR2', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453178, 'HP:5000005', 'Anti-CASPR2', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453179, 'HP:5000005', 'Anti-CASPR2', 'MP:0001849', 'ear inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453180, 'HP:5000005', 'Anti-CASPR2', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453181, 'HP:5000005', 'Anti-CASPR2', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453182, 'HP:5000005', 'Anti-CASPR2', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453183, 'HP:5000005', 'Anti-CASPR2', 'MP:0005253', 'abnormal eye physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453184, 'HP:5000005', 'Anti-CASPR2', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453185, 'HP:5000005', 'Anti-CASPR2', 'MP:0008663', 'increased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453186, 'HP:5000005', 'Anti-CASPR2', 'MP:0002314', 'abnormal respiratory mechanics', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453187, 'HP:5000005', 'Anti-CASPR2', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453188, 'HP:5000005', 'Anti-CASPR2', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453189, 'HP:5000005', 'Anti-CASPR2', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453190, 'HP:5000005', 'Anti-CASPR2', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453191, 'HP:5000005', 'Anti-CASPR2', 'MP:0001924', 'infertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453192, 'HP:5000005', 'Anti-CASPR2', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453193, 'HP:5000005', 'Anti-CASPR2', 'MP:0003925', 'abnormal cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453194, 'HP:5000005', 'Anti-CASPR2', 'MP:0003674', 'oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453195, 'HP:5000005', 'Anti-CASPR2', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453196, 'HP:5000005', 'Anti-CASPR2', 'MP:0002064', 'seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453197, 'HP:5000005', 'Anti-CASPR2', 'MP:0001866', 'nasal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453198, 'HP:5000005', 'Anti-CASPR2', 'MP:0020000', 'abnormal response to antigen', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453199, 'HP:5000005', 'Anti-CASPR2', 'MP:0003303', 'peritoneal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453200, 'HP:5000005', 'Anti-CASPR2', 'MP:0010756', 'decreased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453201, 'HP:5000005', 'Anti-CASPR2', 'MP:0001867', 'rhinitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453202, 'HP:5000005', 'Anti-CASPR2', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453203, 'HP:5000005', 'Anti-CASPR2', 'MP:0006138', 'congestive heart failure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453204, 'HP:5000005', 'Anti-CASPR2', 'MP:0000343', 'abnormal response to cardiac infarction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453205, 'HP:5000005', 'Anti-CASPR2', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453206, 'HP:5000005', 'Anti-CASPR2', 'MP:0000352', 'decreased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453207, 'HP:5000005', 'Anti-CASPR2', 'MP:0004510', 'myositis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453208, 'HP:5000005', 'Anti-CASPR2', 'MP:0001800', 'abnormal humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453209, 'HP:5000005', 'Anti-CASPR2', 'MP:0003882', 'abnormal pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453210, 'HP:5000005', 'Anti-CASPR2', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453211, 'HP:5000005', 'Anti-CASPR2', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453212, 'HP:5000005', 'Anti-CASPR2', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453213, 'HP:5000005', 'Anti-CASPR2', 'MP:0011518', 'abnormal cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453214, 'HP:5000005', 'Anti-CASPR2', 'MP:0006080', 'brain ischemia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453215, 'HP:5000005', 'Anti-CASPR2', 'MP:0003280', 'urinary incontinence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453216, 'HP:5000005', 'Anti-CASPR2', 'MP:0020154', 'impaired humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453217, 'HP:5000005', 'Anti-CASPR2', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453218, 'HP:5000005', 'Anti-CASPR2', 'MP:0003726', 'decreased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453219, 'HP:5000005', 'Anti-CASPR2', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453220, 'HP:5000005', 'Anti-CASPR2', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453221, 'HP:5000005', 'Anti-CASPR2', 'MP:0011809', 'abnormal anoikis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453222, 'HP:5000005', 'Anti-CASPR2', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453223, 'HP:5000005', 'Anti-CASPR2', 'MP:0012608', 'abnormal complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453224, 'HP:5000005', 'Anti-CASPR2', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453225, 'HP:5000005', 'Anti-CASPR2', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453226, 'HP:5000005', 'Anti-CASPR2', 'MP:0020941', 'decreased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453227, 'HP:5000005', 'Anti-CASPR2', 'MP:0002693', 'abnormal pancreas physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453228, 'HP:5000005', 'Anti-CASPR2', 'MP:0003777', 'lip inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453229, 'HP:5000005', 'Anti-CASPR2', 'MP:0002993', 'arthritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453230, 'HP:5000005', 'Anti-CASPR2', 'MP:0003823', 'increased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453231, 'HP:5000005', 'Anti-CASPR2', 'MP:0004122', 'abnormal sinus arrhythmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453232, 'HP:5000005', 'Anti-CASPR2', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453233, 'HP:5000005', 'Anti-CASPR2', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453234, 'HP:5000005', 'Anti-CASPR2', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453235, 'HP:5000005', 'Anti-CASPR2', 'MP:0021016', 'decreased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453236, 'HP:5000005', 'Anti-CASPR2', 'MP:0031424', 'enhanced female fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453237, 'HP:5000005', 'Anti-CASPR2', 'MP:0001873', 'stomach inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453238, 'HP:5000005', 'Anti-CASPR2', 'MP:0001847', 'brain inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453239, 'HP:5000005', 'Anti-CASPR2', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453240, 'HP:5000005', 'Anti-CASPR2', 'MP:0004781', 'abnormal surfactant composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453241, 'HP:5000005', 'Anti-CASPR2', 'MP:0000350', 'abnormal cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453242, 'HP:5000005', 'Anti-CASPR2', 'MP:0009792', 'seborrheic dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453243, 'HP:5000005', 'Anti-CASPR2', 'MP:0001598', 'abnormal blood viscosity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453244, 'HP:5000005', 'Anti-CASPR2', 'MP:0002333', 'abnormal lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453245, 'HP:5000005', 'Anti-CASPR2', 'MP:0004752', 'decreased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453246, 'HP:5000005', 'Anti-CASPR2', 'MP:0011717', 'increased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453247, 'HP:5000005', 'Anti-CASPR2', 'MP:0020414', 'abnormal fibroblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453248, 'HP:5000005', 'Anti-CASPR2', 'MP:0004877', 'abnormal systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453249, 'HP:5000005', 'Anti-CASPR2', 'MP:0001984', 'abnormal olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453250, 'HP:5000005', 'Anti-CASPR2', 'MP:0008651', 'increased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453251, 'HP:5000005', 'Anti-CASPR2', 'MP:0005620', 'abnormal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453252, 'HP:5000005', 'Anti-CASPR2', 'MP:0011918', 'abnormal PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453253, 'HP:5000005', 'Anti-CASPR2', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453254, 'HP:5000005', 'Anti-CASPR2', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453255, 'HP:5000005', 'Anti-CASPR2', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453256, 'HP:5000005', 'Anti-CASPR2', 'MP:0012565', 'perivasculitis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453257, 'HP:5000005', 'Anti-CASPR2', 'MP:0001986', 'abnormal taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453258, 'HP:5000005', 'Anti-CASPR2', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453259, 'HP:5000005', 'Anti-CASPR2', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453260, 'HP:5000005', 'Anti-CASPR2', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453261, 'HP:5000005', 'Anti-CASPR2', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453262, 'HP:5000005', 'Anti-CASPR2', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453263, 'HP:5000005', 'Anti-CASPR2', 'MP:0008564', 'increased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453264, 'HP:5000005', 'Anti-CASPR2', 'MP:0030988', 'dysosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453265, 'HP:5000005', 'Anti-CASPR2', 'MP:0008544', 'impaired olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453266, 'HP:5000005', 'Anti-CASPR2', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453267, 'HP:5000005', 'Anti-CASPR2', 'MP:0008004', 'abnormal stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453268, 'HP:5000005', 'Anti-CASPR2', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453269, 'HP:5000005', 'Anti-CASPR2', 'MP:0031402', 'decreased muscle fatigability', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453270, 'HP:5000005', 'Anti-CASPR2', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453271, 'HP:5000005', 'Anti-CASPR2', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453272, 'HP:5000005', 'Anti-CASPR2', 'MP:0005043', 'defective assembly of class II molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453273, 'HP:5000005', 'Anti-CASPR2', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453274, 'HP:5000005', 'Anti-CASPR2', 'MP:0005088', 'increased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453275, 'HP:5000005', 'Anti-CASPR2', 'MP:0005364', 'increased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453276, 'HP:5000005', 'Anti-CASPR2', 'MP:0010680', 'abnormal skin adnexa physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453277, 'HP:5000005', 'Anti-CASPR2', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453278, 'HP:5000005', 'Anti-CASPR2', 'MP:0003157', 'impaired muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453279, 'HP:5000005', 'Anti-CASPR2', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453280, 'HP:5000005', 'Anti-CASPR2', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453281, 'HP:5000005', 'Anti-CASPR2', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453282, 'HP:5000005', 'Anti-CASPR2', 'MP:0008722', 'abnormal chemokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453283, 'HP:5000005', 'Anti-CASPR2', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453284, 'HP:5000005', 'Anti-CASPR2', 'MP:0013634', 'increased femur fracture load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453285, 'HP:5000005', 'Anti-CASPR2', 'MP:0002322', 'abnormal respiratory transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453286, 'HP:5000005', 'Anti-CASPR2', 'MP:0008699', 'increased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453287, 'HP:5000005', 'Anti-CASPR2', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453288, 'HP:5000005', 'Anti-CASPR2', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453289, 'HP:5000005', 'Anti-CASPR2', 'MP:0013636', 'abnormal bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453290, 'HP:5000005', 'Anti-CASPR2', 'MP:0008260', 'abnormal autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453291, 'HP:5000005', 'Anti-CASPR2', 'MP:0010505', 'abnormal T wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453292, 'HP:5000005', 'Anti-CASPR2', 'MP:0021015', 'increased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453293, 'HP:5000005', 'Anti-CASPR2', 'MP:0002330', 'abnormal bronchial provocation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453294, 'HP:5000005', 'Anti-CASPR2', 'MP:0003091', 'abnormal cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453295, 'HP:5000005', 'Anti-CASPR2', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453296, 'HP:5000005', 'Anti-CASPR2', 'MP:0005580', 'periinsulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453297, 'HP:5000005', 'Anti-CASPR2', 'MP:0031102', 'rhinorrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453298, 'HP:5000005', 'Anti-CASPR2', 'MP:0031240', 'abnormal CSF3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453299, 'HP:5000005', 'Anti-CASPR2', 'MP:0020934', 'increased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453300, 'HP:5000005', 'Anti-CASPR2', 'MP:0008562', 'increased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453301, 'HP:5000005', 'Anti-CASPR2', 'MP:0013557', 'abnormal merocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453302, 'HP:5000005', 'Anti-CASPR2', 'MP:0001858', 'intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453303, 'HP:5000005', 'Anti-CASPR2', 'MP:0031098', 'abnormal sputum production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453304, 'HP:5000005', 'Anti-CASPR2', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453305, 'HP:5000005', 'Anti-CASPR2', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453306, 'HP:5000005', 'Anti-CASPR2', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453307, 'HP:5000005', 'Anti-CASPR2', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453308, 'HP:5000005', 'Anti-CASPR2', 'MP:0008747', 'abnormal T cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453309, 'HP:5000005', 'Anti-CASPR2', 'MP:0011566', 'abnormal complement protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453310, 'HP:5000005', 'Anti-CASPR2', 'MP:0001845', 'abnormal inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453311, 'HP:5000005', 'Anti-CASPR2', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453312, 'HP:5000005', 'Anti-CASPR2', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453313, 'HP:5000005', 'Anti-CASPR2', 'MP:0020944', 'decreased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453314, 'HP:5000005', 'Anti-CASPR2', 'MP:0003477', 'abnormal nerve fiber response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453315, 'HP:5000005', 'Anti-CASPR2', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453316, 'HP:5000005', 'Anti-CASPR2', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453317, 'HP:5000005', 'Anti-CASPR2', 'MP:0013642', 'decreased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453318, 'HP:5000005', 'Anti-CASPR2', 'MP:0010822', 'pneumothorax', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453319, 'HP:5000005', 'Anti-CASPR2', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453320, 'HP:5000005', 'Anti-CASPR2', 'MP:0002842', 'increased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453321, 'HP:5000005', 'Anti-CASPR2', 'MP:0002578', 'impaired ability to fire action potentials', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453322, 'HP:5000005', 'Anti-CASPR2', 'MP:0013135', 'poor circulation in tail', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453323, 'HP:5000005', 'Anti-CASPR2', 'MP:0001664', 'abnormal digestion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453324, 'HP:5000005', 'Anti-CASPR2', 'MP:0030990', 'nerve inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453325, 'HP:5000005', 'Anti-CASPR2', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453326, 'HP:5000005', 'Anti-CASPR2', 'MP:0000740', 'impaired smooth muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453327, 'HP:5000005', 'Anti-CASPR2', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453328, 'HP:5000005', 'Anti-CASPR2', 'MP:0004037', 'increased muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453329, 'HP:5000005', 'Anti-CASPR2', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453330, 'HP:5000005', 'Anti-CASPR2', 'MP:0002421', 'abnormal cell-mediated immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453331, 'HP:5000005', 'Anti-CASPR2', 'MP:0008664', 'decreased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453332, 'HP:5000005', 'Anti-CASPR2', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453333, 'HP:5000005', 'Anti-CASPR2', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453334, 'HP:5000005', 'Anti-CASPR2', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453335, 'HP:5000005', 'Anti-CASPR2', 'MP:0002723', 'abnormal immune serum protein physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453336, 'HP:5000005', 'Anti-CASPR2', 'MP:0002164', 'abnormal gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453337, 'HP:5000005', 'Anti-CASPR2', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453338, 'HP:5000005', 'Anti-CASPR2', 'MP:0004994', 'abnormal brain wave pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453339, 'HP:5000005', 'Anti-CASPR2', 'MP:0013637', 'increased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453340, 'HP:5000005', 'Anti-CASPR2', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453341, 'HP:5000005', 'Anti-CASPR2', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453342, 'HP:5000005', 'Anti-CASPR2', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453343, 'HP:5000005', 'Anti-CASPR2', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453344, 'HP:5000005', 'Anti-CASPR2', 'MP:0014274', 'decreased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453345, 'HP:5000005', 'Anti-CASPR2', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453346, 'HP:5000005', 'Anti-CASPR2', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453347, 'HP:5000005', 'Anti-CASPR2', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453348, 'HP:5000005', 'Anti-CASPR2', 'MP:0010071', 'abnormal pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453349, 'HP:5000005', 'Anti-CASPR2', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453350, 'HP:5000005', 'Anti-CASPR2', 'MP:0001790', 'abnormal immune system physiology', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453351, 'HP:5000005', 'Anti-CASPR2', 'MP:0011043', 'abnormal lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453352, 'HP:5000005', 'Anti-CASPR2', 'MP:0003878', 'abnormal ear physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453353, 'HP:5000005', 'Anti-CASPR2', 'MP:0030132', 'periodontium inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453354, 'HP:5000005', 'Anti-CASPR2', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453355, 'HP:5000005', 'Anti-CASPR2', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453356, 'HP:5000005', 'Anti-CASPR2', 'MP:0013806', 'encephalopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453357, 'HP:5000005', 'Anti-CASPR2', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453358, 'HP:5000005', 'Anti-CASPR2', 'MP:0030991', 'optic nerve inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453359, 'HP:5000005', 'Anti-CASPR2', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453360, 'HP:5000005', 'Anti-CASPR2', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453361, 'HP:5000005', 'Anti-CASPR2', 'MP:0010560', 'intraventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453362, 'HP:5000005', 'Anti-CASPR2', 'MP:0008669', 'increased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453363, 'HP:5000005', 'Anti-CASPR2', 'MP:0001542', 'abnormal bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453364, 'HP:5000005', 'Anti-CASPR2', 'MP:0001633', 'poor circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453365, 'HP:5000005', 'Anti-CASPR2', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453366, 'HP:5000005', 'Anti-CASPR2', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453367, 'HP:5000005', 'Anti-CASPR2', 'MP:0000427', 'abnormal hair cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453368, 'HP:5000005', 'Anti-CASPR2', 'MP:0008003', 'achlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453369, 'HP:5000005', 'Anti-CASPR2', 'MP:0003725', 'increased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453370, 'HP:5000005', 'Anti-CASPR2', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453371, 'HP:5000005', 'Anti-CASPR2', 'MP:0013640', 'increased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453372, 'HP:5000005', 'Anti-CASPR2', 'MP:0003116', 'rickets', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453373, 'HP:5000005', 'Anti-CASPR2', 'MP:0031013', 'abnormal egg activation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453374, 'HP:5000005', 'Anti-CASPR2', 'MP:0013136', 'genital discharge', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453375, 'HP:5000005', 'Anti-CASPR2', 'MP:0005532', 'abnormal vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453376, 'HP:5000005', 'Anti-CASPR2', 'MP:0008007', 'abnormal cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453377, 'HP:5000005', 'Anti-CASPR2', 'MP:0009473', 'abnormal skin exfoliation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453378, 'HP:5000005', 'Anti-CASPR2', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453379, 'HP:5000005', 'Anti-CASPR2', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453380, 'HP:5000005', 'Anti-CASPR2', 'MP:0013475', 'delayed reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453381, 'HP:5000005', 'Anti-CASPR2', 'MP:0001837', 'defective assembly of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453382, 'HP:5000005', 'Anti-CASPR2', 'MP:0009562', 'abnormal odor adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453383, 'HP:5000005', 'Anti-CASPR2', 'MP:0012382', 'abnormal blood cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453384, 'HP:5000005', 'Anti-CASPR2', 'MP:0031125', 'aspiration pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453385, 'HP:5000005', 'Anti-CASPR2', 'MP:0000743', 'muscle spasm', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453386, 'HP:5000005', 'Anti-CASPR2', 'MP:0008776', 'increased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453387, 'HP:5000005', 'Anti-CASPR2', 'MP:0003762', 'abnormal immune organ physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453388, 'HP:5000005', 'Anti-CASPR2', 'MP:0011764', 'ureteritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453389, 'HP:5000005', 'Anti-CASPR2', 'MP:0005076', 'abnormal cell differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453390, 'HP:5000005', 'Anti-CASPR2', 'MP:0008751', 'abnormal interleukin level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453391, 'HP:5000005', 'Anti-CASPR2', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453392, 'HP:5000005', 'Anti-CASPR2', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453393, 'HP:5000005', 'Anti-CASPR2', 'MP:0031051', 'lymph node hemorrhage', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453394, 'HP:5000005', 'Anti-CASPR2', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453395, 'HP:5000005', 'Anti-CASPR2', 'MP:0010758', 'increased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453396, 'HP:5000005', 'Anti-CASPR2', 'MP:0004010', 'increased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453397, 'HP:5000005', 'Anti-CASPR2', 'MP:0008678', 'increased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453398, 'HP:5000005', 'Anti-CASPR2', 'MP:0012556', 'increased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453399, 'HP:5000005', 'Anti-CASPR2', 'MP:0002161', 'abnormal fertility/fecundity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453400, 'HP:5000005', 'Anti-CASPR2', 'MP:0004009', 'abnormal diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453401, 'HP:5000005', 'Anti-CASPR2', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453402, 'HP:5000005', 'Anti-CASPR2', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453403, 'HP:5000005', 'Anti-CASPR2', 'MP:0020147', 'abnormal defecation amount', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453404, 'HP:5000005', 'Anti-CASPR2', 'MP:0008744', 'abnormal B cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453405, 'HP:5000005', 'Anti-CASPR2', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453406, 'HP:5000005', 'Anti-CASPR2', 'MP:0020935', 'decreased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453407, 'HP:5000005', 'Anti-CASPR2', 'MP:0010073', 'decreased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453408, 'HP:5000005', 'Anti-CASPR2', 'MP:0020845', 'abnormal DNA-templated transcription', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453409, 'HP:5000005', 'Anti-CASPR2', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453410, 'HP:5000005', 'Anti-CASPR2', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453411, 'HP:5000005', 'Anti-CASPR2', 'MP:0031104', 'crackles', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453412, 'HP:5000005', 'Anti-CASPR2', 'MP:0011048', 'decreased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453413, 'HP:5000005', 'Anti-CASPR2', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453414, 'HP:5000005', 'Anti-CASPR2', 'MP:0012111', 'failure of morula compaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453415, 'HP:5000005', 'Anti-CASPR2', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453416, 'HP:5000005', 'Anti-CASPR2', 'MP:0030216', 'tongue muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453417, 'HP:5000005', 'Anti-CASPR2', 'MP:0002418', 'increased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453418, 'HP:5000005', 'Anti-CASPR2', 'MP:0001864', 'vascular inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453419, 'HP:5000005', 'Anti-CASPR2', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453420, 'HP:5000005', 'Anti-CASPR2', 'MP:0031129', 'left-to-right shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453421, 'HP:5000005', 'Anti-CASPR2', 'MP:0020097', 'low mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453422, 'HP:5000005', 'Anti-CASPR2', 'MP:0030822', 'sacroiliac joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453423, 'HP:5000005', 'Anti-CASPR2', 'MP:0010994', 'aerophagia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453424, 'HP:5000005', 'Anti-CASPR2', 'MP:0001921', 'reduced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453425, 'HP:5000005', 'Anti-CASPR2', 'MP:0005005', 'abnormal self tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453426, 'HP:5000005', 'Anti-CASPR2', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453427, 'HP:5000005', 'Anti-CASPR2', 'MP:0002296', 'aspiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453428, 'HP:5000005', 'Anti-CASPR2', 'MP:0001793', 'abnormal susceptibility to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453429, 'HP:5000005', 'Anti-CASPR2', 'MP:0010552', 'abnormal HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453430, 'HP:5000005', 'Anti-CASPR2', 'MP:0001840', 'increased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453431, 'HP:5000005', 'Anti-CASPR2', 'MP:0011805', 'decreased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453432, 'HP:5000005', 'Anti-CASPR2', 'MP:0020039', 'increased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453433, 'HP:5000005', 'Anti-CASPR2', 'MP:0004211', 'abnormal sour taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453434, 'HP:5000005', 'Anti-CASPR2', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453435, 'HP:5000005', 'Anti-CASPR2', 'MP:0012554', 'increased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453436, 'HP:5000005', 'Anti-CASPR2', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453437, 'HP:5000005', 'Anti-CASPR2', 'MP:0004796', 'increased anti-histone antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453438, 'HP:5000005', 'Anti-CASPR2', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453439, 'HP:5000005', 'Anti-CASPR2', 'MP:0004484', 'abnormal response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453440, 'HP:5000005', 'Anti-CASPR2', 'MP:0009057', 'increased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453441, 'HP:5000005', 'Anti-CASPR2', 'MP:0031111', 'meningoencephalitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453442, 'HP:5000005', 'Anti-CASPR2', 'MP:0003298', 'choking', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453443, 'HP:5000005', 'Anti-CASPR2', 'MP:0013942', 'enthesitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453444, 'HP:5000005', 'Anti-CASPR2', 'MP:0003009', 'abnormal cytokine secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453445, 'HP:5000005', 'Anti-CASPR2', 'MP:0003746', 'stomatitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453446, 'HP:5000005', 'Anti-CASPR2', 'MP:0001869', 'pancreas inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453447, 'HP:5000005', 'Anti-CASPR2', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453448, 'HP:5000005', 'Anti-CASPR2', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453449, 'HP:5000005', 'Anti-CASPR2', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453450, 'HP:5000005', 'Anti-CASPR2', 'MP:0011920', 'abnormal S wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453451, 'HP:5000005', 'Anti-CASPR2', 'MP:0006082', 'CNS inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453452, 'HP:5000005', 'Anti-CASPR2', 'MP:0010539', 'decreased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453453, 'HP:5000005', 'Anti-CASPR2', 'MP:0009046', 'muscle twitch', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453454, 'HP:5000005', 'Anti-CASPR2', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453455, 'HP:5000005', 'Anti-CASPR2', 'MP:0011919', 'abnormal R wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453456, 'HP:5000005', 'Anti-CASPR2', 'MP:0031089', 'sneezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453457, 'HP:5000005', 'Anti-CASPR2', 'MP:0011927', 'abnormal cardiac valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453458, 'HP:5000005', 'Anti-CASPR2', 'MP:0008566', 'increased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453459, 'HP:5000005', 'Anti-CASPR2', 'MP:0012553', 'decreased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453460, 'HP:5000005', 'Anti-CASPR2', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453461, 'HP:5000005', 'Anti-CASPR2', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453462, 'HP:5000005', 'Anti-CASPR2', 'MP:0003865', 'lymph node inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453463, 'HP:5000005', 'Anti-CASPR2', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453464, 'HP:5000005', 'Anti-CASPR2', 'MP:0008675', 'increased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453465, 'HP:5000005', 'Anti-CASPR2', 'MP:0001666', 'abnormal intestinal absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453466, 'HP:5000005', 'Anti-CASPR2', 'MP:0014037', 'stranguria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453467, 'HP:5000005', 'Anti-CASPR2', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453468, 'HP:5000005', 'Anti-CASPR2', 'MP:0002694', 'abnormal pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453469, 'HP:5000005', 'Anti-CASPR2', 'MP:0004011', 'decreased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453470, 'HP:5000005', 'Anti-CASPR2', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453471, 'HP:5000005', 'Anti-CASPR2', 'MP:0000316', 'cellular necrosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453472, 'HP:5000005', 'Anti-CASPR2', 'MP:0001862', 'interstitial pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453473, 'HP:5000005', 'Anti-CASPR2', 'MP:0003393', 'decreased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453474, 'HP:5000005', 'Anti-CASPR2', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453475, 'HP:5000005', 'Anti-CASPR2', 'MP:0000351', 'increased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453476, 'HP:5000005', 'Anti-CASPR2', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453477, 'HP:5000005', 'Anti-CASPR2', 'MP:0010211', 'abnormal acute phase protein level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453478, 'HP:5000005', 'Anti-CASPR2', 'MP:0020938', 'decreased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453479, 'HP:5000005', 'Anti-CASPR2', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453480, 'HP:5000005', 'Anti-CASPR2', 'MP:0031241', 'decreased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453481, 'HP:5000005', 'Anti-CASPR2', 'MP:0003767', 'palate inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453482, 'HP:5000005', 'Anti-CASPR2', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453483, 'HP:5000005', 'Anti-CASPR2', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453484, 'HP:5000005', 'Anti-CASPR2', 'MP:0011045', 'decreased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453485, 'HP:5000005', 'Anti-CASPR2', 'MP:0004782', 'abnormal surfactant physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453486, 'HP:5000005', 'Anti-CASPR2', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453487, 'HP:5000005', 'Anti-CASPR2', 'MP:0001634', 'internal hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453488, 'HP:5000005', 'Anti-CASPR2', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453489, 'HP:5000005', 'Anti-CASPR2', 'MP:0001851', 'eye inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453490, 'HP:5000005', 'Anti-CASPR2', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453491, 'HP:5000005', 'Anti-CASPR2', 'MP:0002634', 'abnormal sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453492, 'HP:5000005', 'Anti-CASPR2', 'MP:0013627', 'increased vertebra yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453493, 'HP:5000005', 'Anti-CASPR2', 'MP:0001648', 'abnormal apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453494, 'HP:5000005', 'Anti-CASPR2', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453495, 'HP:5000005', 'Anti-CASPR2', 'MP:0004149', 'increased bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453496, 'HP:5000005', 'Anti-CASPR2', 'MP:0012006', 'abnormal hippocampus physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453497, 'HP:5000005', 'Anti-CASPR2', 'MP:0004036', 'abnormal muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453498, 'HP:5000005', 'Anti-CASPR2', 'MP:0001951', 'abnormal breathing pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453499, 'HP:5000005', 'Anti-CASPR2', 'MP:0003079', 'decreased susceptibility to induced joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453500, 'HP:5000005', 'Anti-CASPR2', 'MP:0020943', 'increased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453501, 'HP:5000005', 'Anti-CASPR2', 'MP:0020950', 'decreased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453502, 'HP:5000005', 'Anti-CASPR2', 'MP:0003278', 'esophageal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453503, 'HP:5000005', 'Anti-CASPR2', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453504, 'HP:5000005', 'Anti-CASPR2', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453505, 'HP:5000005', 'Anti-CASPR2', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453506, 'HP:5000005', 'Anti-CASPR2', 'MP:0008660', 'increased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453507, 'HP:5000005', 'Anti-CASPR2', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453508, 'HP:5000005', 'Anti-CASPR2', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453509, 'HP:5000005', 'Anti-CASPR2', 'MP:0002473', 'impaired complement classical pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453510, 'HP:5000005', 'Anti-CASPR2', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453511, 'HP:5000005', 'Anti-CASPR2', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453512, 'HP:5000005', 'Anti-CASPR2', 'MP:0002327', 'abnormal respiratory function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453513, 'HP:5000005', 'Anti-CASPR2', 'MP:0010922', 'alveolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453514, 'HP:5000005', 'Anti-CASPR2', 'MP:0008702', 'increased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453515, 'HP:5000005', 'Anti-CASPR2', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453516, 'HP:5000005', 'Anti-CASPR2', 'MP:0020949', 'increased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453517, 'HP:5000005', 'Anti-CASPR2', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453518, 'HP:5000005', 'Anti-CASPR2', 'MP:0013752', 'stridor', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453519, 'HP:5000005', 'Anti-CASPR2', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453520, 'HP:5000005', 'Anti-CASPR2', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453521, 'HP:5000005', 'Anti-CASPR2', 'MP:0012555', 'decreased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453522, 'HP:5000005', 'Anti-CASPR2', 'MP:0009062', 'impaired lectin complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453523, 'HP:5000005', 'Anti-CASPR2', 'MP:0005671', 'abnormal response to transplant', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453524, 'HP:5000005', 'Anti-CASPR2', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(453525, 'HP:5000005', 'Anti-CASPR2', 'MP:0002841', 'impaired skeletal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453526, 'HP:0011787', 'Central hypothyroidism', 'MP:0010147', 'abnormal endocrine pancreas physiology', 0.4166666666666667, 10.708293991368175, 2.1122947623544572, 'UPHENO:0002388', 'abnormality of endocrine gland physiology'),
(453527, 'HP:0011787', 'Central hypothyroidism', 'MP:0003431', 'abnormal parathyroid gland physiology', 0.4411764705882353, 10.708293991368175, 2.173533378886328, 'UPHENO:0002388', 'abnormality of endocrine gland physiology'),
(453528, 'HP:0011787', 'Central hypothyroidism', 'MP:0002164', 'abnormal gland physiology', 0.43333333333333335, 9.740898656800104, 2.0545208893105413, 'UPHENO:0002261', 'abnormality of gland physiology'),
(453529, 'HP:0011787', 'Central hypothyroidism', 'MP:0003504', 'thyroid gland inflammation', 0.4358974358974359, 12.548253578857707, 2.3387499994687113, 'UPHENO:0002325', 'abnormality of thyroid gland physiology'),
(453530, 'HP:0011787', 'Central hypothyroidism', 'MP:0002876', 'abnormal thyroid gland physiology', 0.53125, 12.548253578857707, 2.581910090179005, 'UPHENO:0002325', 'abnormality of thyroid gland physiology'),
(453531, 'HP:0011787', 'Central hypothyroidism', 'MP:0001744', 'hypersecretion of corticosterone', 0.4166666666666667, 10.708293991368175, 2.1122947623544572, 'UPHENO:0002388', 'abnormality of endocrine gland physiology'),
(453532, 'HP:0011787', 'Central hypothyroidism', 'MP:0011911', 'abnormal pancreatic endocrine progenitor cell physiology', 0.40540540540540543, 10.708293991368175, 2.0835547189288985, 'UPHENO:0002388', 'abnormality of endocrine gland physiology'),
(453533, 'HP:0011787', 'Central hypothyroidism', 'MP:0003432', 'increased activity of parathyroid', 0.42857142857142855, 10.708293991368175, 2.142257886773556, 'UPHENO:0002388', 'abnormality of endocrine gland physiology'),
(453534, 'HP:0011787', 'Central hypothyroidism', 'MP:0003433', 'decreased activity of parathyroid', 0.42857142857142855, 10.708293991368175, 2.142257886773556, 'UPHENO:0002388', 'abnormality of endocrine gland physiology'),
(453535, 'HP:0011787', 'Central hypothyroidism', 'MP:0003502', 'increased activity of thyroid gland', 0.5151515151515151, 12.548253578857707, 2.542489300597737, 'UPHENO:0002325', 'abnormality of thyroid gland physiology'),
(453536, 'HP:0011787', 'Central hypothyroidism', 'MP:0003325', 'decreased liver function', 0.40476190476190477, 10.708293991368175, 2.081900447354926, 'UPHENO:0002388', 'abnormality of endocrine gland physiology'),
(453537, 'HP:0011787', 'Central hypothyroidism', 'MP:0003503', 'decreased activity of thyroid gland', 0.6060606060606061, 15.022184767190119, 3.0173422749760506, 'UPHENO:0066918', 'abnormally decreased functionality of the thyroid gland'),
(453538, 'HP:0011787', 'Central hypothyroidism', 'MP:0013570', 'abnormal neuroendocrine gland physiology', 0.40540540540540543, 10.708293991368175, 2.0835547189288985, 'UPHENO:0002388', 'abnormality of endocrine gland physiology'),
(453539, 'HP:0011787', 'Central hypothyroidism', 'MP:0013559', 'abnormal exocrine gland physiology', 0.40625, 9.740898656800104, 1.9892812971837448, 'UPHENO:0002261', 'abnormality of gland physiology'),
(453540, 'HP:0011787', 'Central hypothyroidism', 'MP:0003501', 'iodide oxidation defect', 0.5151515151515151, 12.548253578857707, 2.542489300597737, 'UPHENO:0002325', 'abnormality of thyroid gland physiology'),
(453541, 'HP:0011787', 'Central hypothyroidism', 'MP:0013561', 'abnormal endocrine gland physiology', 0.4838709677419355, 10.708293991368175, 2.276276032573482, 'UPHENO:0002388', 'abnormality of endocrine gland physiology'),
(453542, 'HP:0011787', 'Central hypothyroidism', 'MP:0002909', 'abnormal adrenal gland physiology', 0.4411764705882353, 10.708293991368175, 2.173533378886328, 'UPHENO:0002388', 'abnormality of endocrine gland physiology'),
(453543, 'HP:0011787', 'Central hypothyroidism', 'MP:0001739', 'abnormal adrenal gland secretion', 0.42857142857142855, 10.708293991368175, 2.142257886773556, 'UPHENO:0002388', 'abnormality of endocrine gland physiology'),
(453544, 'HP:0025172', 'Smooth septal thickening on pulmonary HRCT', 'MP:0002337', 'abnormal whole-body plethysmography', 0.45454545454545453, 9.915985363358194, 2.123032282904272, 'UPHENO:0019970', 'abnormal lung morphology'),
(453545, 'HP:0025172', 'Smooth septal thickening on pulmonary HRCT', 'MP:0010857', 'pulmonary necrosis', 0.41304347826086957, 9.915985363358194, 2.023791759264115, 'UPHENO:0019970', 'abnormal lung morphology'),
(453546, 'HP:0025172', 'Smooth septal thickening on pulmonary HRCT', 'MP:0010938', 'decreased total lung capacity', 0.43478260869565216, 9.915985363358194, 2.0763665341333115, 'UPHENO:0019970', 'abnormal lung morphology'),
(453547, 'HP:0025172', 'Smooth septal thickening on pulmonary HRCT', 'MP:0002306', 'abnormal functional residual capacity', 0.45454545454545453, 9.915985363358194, 2.123032282904272, 'UPHENO:0019970', 'abnormal lung morphology'),
(453548, 'HP:0025172', 'Smooth septal thickening on pulmonary HRCT', 'MP:0002308', 'abnormal residual volume', 0.45454545454545453, 9.915985363358194, 2.123032282904272, 'UPHENO:0019970', 'abnormal lung morphology'),
(453549, 'HP:0025172', 'Smooth septal thickening on pulmonary HRCT', 'MP:0002313', 'abnormal tidal volume', 0.45454545454545453, 9.915985363358194, 2.123032282904272, 'UPHENO:0019970', 'abnormal lung morphology'),
(453550, 'HP:0025172', 'Smooth septal thickening on pulmonary HRCT', 'MP:0002312', 'abnormal inspiratory reserve volume', 0.45454545454545453, 9.915985363358194, 2.123032282904272, 'UPHENO:0019970', 'abnormal lung morphology'),
(453551, 'HP:0025172', 'Smooth septal thickening on pulmonary HRCT', 'MP:0005585', 'increased tidal volume', 0.4444444444444444, 9.915985363358194, 2.099310507270655, 'UPHENO:0019970', 'abnormal lung morphology'),
(453552, 'HP:0025172', 'Smooth septal thickening on pulmonary HRCT', 'MP:0002304', 'abnormal total lung capacity', 0.4444444444444444, 9.915985363358194, 2.099310507270655, 'UPHENO:0019970', 'abnormal lung morphology'),
(453553, 'HP:0025172', 'Smooth septal thickening on pulmonary HRCT', 'MP:0002311', 'abnormal inspiratory capacity', 0.45454545454545453, 9.915985363358194, 2.123032282904272, 'UPHENO:0019970', 'abnormal lung morphology'),
(453554, 'HP:0025172', 'Smooth septal thickening on pulmonary HRCT', 'MP:0004881', 'abnormal lung size', 0.425, 9.915985363358194, 2.052874516239907, 'UPHENO:0019970', 'abnormal lung morphology'),
(453555, 'HP:0025172', 'Smooth septal thickening on pulmonary HRCT', 'MP:0006050', 'pulmonary fibrosis', 0.425, 9.915985363358194, 2.052874516239907, 'UPHENO:0019970', 'abnormal lung morphology'),
(453556, 'HP:0025172', 'Smooth septal thickening on pulmonary HRCT', 'MP:0005586', 'decreased tidal volume', 0.4444444444444444, 9.915985363358194, 2.099310507270655, 'UPHENO:0019970', 'abnormal lung morphology'),
(453557, 'HP:0025172', 'Smooth septal thickening on pulmonary HRCT', 'MP:0002309', 'abnormal vital capacity', 0.45454545454545453, 9.915985363358194, 2.123032282904272, 'UPHENO:0019970', 'abnormal lung morphology'),
(453558, 'HP:0025172', 'Smooth septal thickening on pulmonary HRCT', 'MP:0001942', 'abnormal lung volume', 0.46511627906976744, 9.915985363358194, 2.1475768241242124, 'UPHENO:0019970', 'abnormal lung morphology'),
(453559, 'HP:0025172', 'Smooth septal thickening on pulmonary HRCT', 'MP:0010937', 'increased total lung capacity', 0.43478260869565216, 9.915985363358194, 2.0763665341333115, 'UPHENO:0019970', 'abnormal lung morphology'),
(453560, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0005410', 'abnormal fertilization', 0.5, 9.708293991368175, 2.203212880246502, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
(453561, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0031437', 'increased copulatory plug deposition', 0.4117647058823529, 9.708293991368175, 1.99938310985542, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
(453562, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0002254', 'reproductive system inflammation', 0.4117647058823529, 9.708293991368175, 1.99938310985542, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
(453563, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0001379', 'abnormal penile erection', 0.4375, 9.708293991368175, 2.0609169370024536, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
(453564, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0002292', 'abnormal gestational length', 0.45161290322580644, 9.708293991368175, 2.093893701889242, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
(453565, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0005621', 'abnormal cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453566, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0031423', 'abnormal luteolysis', 0.4375, 9.708293991368175, 2.0609169370024536, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
(453567, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0010680', 'abnormal skin adnexa physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453568, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0009020', 'prolonged metestrus', 0.4117647058823529, 9.708293991368175, 1.99938310985542, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
(453569, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0000427', 'abnormal hair cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453570, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0009006', 'prolonged estrous cycle', 0.42424242424242425, 9.708293991368175, 2.0294507084815328, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
(453571, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453572, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0009009', 'absent estrous cycle', 0.42424242424242425, 9.708293991368175, 2.0294507084815328, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
(453573, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0030982', 'abnormal copulatory plug deposition', 0.42424242424242425, 9.708293991368175, 2.0294507084815328, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
(453574, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453575, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0009344', 'abnormal ovulation cycle', 0.45161290322580644, 9.708293991368175, 2.093893701889242, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
(453576, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0012010', 'parturition failure', 0.42424242424242425, 9.708293991368175, 2.0294507084815328, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
(453577, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0001924', 'infertility', 0.4827586206896552, 9.708293991368175, 2.164893211343822, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
(453578, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0009352', 'impaired spacing of implantation sites', 0.42424242424242425, 9.708293991368175, 2.0294507084815328, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
(453579, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0014190', 'abnormal epididymis physiology', 0.42424242424242425, 9.708293991368175, 2.0294507084815328, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
(453580, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0031009', 'abnormal sperm-egg fusion', 0.4827586206896552, 9.708293991368175, 2.164893211343822, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
(453581, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0002294', 'short gestation period', 0.4375, 9.708293991368175, 2.0609169370024536, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
(453582, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0001985', 'abnormal gustatory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453583, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0012018', 'abnormal oviduct physiology', 0.42424242424242425, 9.708293991368175, 2.0294507084815328, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
(453584, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0010143', 'enhanced fertility', 0.4827586206896552, 9.708293991368175, 2.164893211343822, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
(453585, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453586, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0002133', 'abnormal respiratory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453587, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0009012', 'short diestrus', 0.4117647058823529, 9.708293991368175, 1.99938310985542, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
(453588, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0000242', 'impaired fertilization', 0.4117647058823529, 9.708293991368175, 1.99938310985542, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
(453589, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0009664', 'abnormal luminal closure', 0.4117647058823529, 9.708293991368175, 1.99938310985542, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
(453590, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0001926', 'female infertility', 0.42424242424242425, 9.708293991368175, 2.0294507084815328, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
(453591, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0031014', 'polyspermy', 0.4666666666666667, 9.708293991368175, 2.1285058599806144, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
(453592, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0001921', 'reduced fertility', 0.4827586206896552, 9.708293991368175, 2.164893211343822, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
(453593, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0009650', 'dormant blastocysts', 0.42424242424242425, 9.708293991368175, 2.0294507084815328, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
(453594, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0001935', 'decreased litter size', 0.45161290322580644, 9.708293991368175, 2.093893701889242, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
(453595, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453596, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0003415', 'priapism', 0.42424242424242425, 9.708293991368175, 2.0294507084815328, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
(453597, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453598, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0013136', 'genital discharge', 0.5, 9.708293991368175, 2.203212880246502, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
(453599, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453600, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0009666', 'abnormal embryo attachment', 0.42424242424242425, 9.708293991368175, 2.0294507084815328, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
(453601, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0002907', 'abnormal parturition', 0.4375, 9.708293991368175, 2.0609169370024536, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
(453602, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0013475', 'delayed reproductive senescence', 0.4827586206896552, 9.708293991368175, 2.164893211343822, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
(453603, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0003699', 'abnormal female reproductive system physiology', 0.4666666666666667, 9.708293991368175, 2.1285058599806144, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
(453604, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0009697', 'abnormal copulation', 0.5, 9.708293991368175, 2.203212880246502, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
(453605, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0001727', 'abnormal embryo implantation', 0.4375, 9.708293991368175, 2.0609169370024536, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
(453606, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453607, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0004244', 'abnormal miscarriage rate', 0.4375, 9.708293991368175, 2.0609169370024536, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
(453608, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0001983', 'abnormal olfactory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453609, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0031433', 'decreased miscarriage rate', 0.42424242424242425, 9.708293991368175, 2.0294507084815328, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
(453610, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0001934', 'increased litter size', 0.45161290322580644, 9.708293991368175, 2.093893701889242, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
(453611, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0003633', 'abnormal nervous system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(453612, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0031013', 'abnormal egg activation', 0.4827586206896552, 9.708293991368175, 2.164893211343822, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
(453613, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0004014', 'abnormal uterine environment', 0.4375, 9.708293991368175, 2.0609169370024536, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
(453614, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0014267', 'decreased sex gland secretion', 0.4117647058823529, 9.708293991368175, 1.99938310985542, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
(453615, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0003698', 'abnormal male reproductive system physiology', 0.4666666666666667, 9.708293991368175, 2.1285058599806144, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
(453616, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0009016', 'abnormal estrus', 0.42424242424242425, 9.708293991368175, 2.0294507084815328, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
(453617, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0009014', 'prolonged proestrus', 0.4117647058823529, 9.708293991368175, 1.99938310985542, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
(453618, 'HP:0034914', 'Oocyte maturation arrest', 'MP:0031436', 'decreased copulatory plug deposition', 0.4117647058823529, 9.708293991368175, 1.99938310985542, 'UPHENO:0002378', 'abnormality of reproductive system physiology'),
